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ABSTRACT OF DISSERTATION
USE OF GENOMIC TOOLS TO DISCOVER THE CAUSE OF
CHAMPAGNE DILUTION COAT COLOR IN HORSES AND TO MAP THE
GENETIC CAUSE OF EXTREME LORDOSIS
IN AMERICAN SADDLEBRED HORSES
Champagne dilution of coat color in horses is caused by dominant gene action.
Three sire families were identified as segregating for this trait. Genome wide linkage
analysis using 104 microsatellite DNA markers was used to map the gene to ECA14
(LOD > 11.0). Four genes, namely SPARC, SLC36A1, SLC36A2 and SLC36A3, were
selected from the region implicated by linkage and their exons sequenced to identify
genetic variation. DNA sequences were compared for two homozygotes for Champagne
dilution, two heterozygotes and two horses without dilution. A single base change in
exon 2 of SLC36A1 was found unique to horses exhibiting Champagne dilution.
SLC36A1 encodes a eukaryote specific proton dependent small amino acid transporter
also known as LYAAT-1 in rats. This change in base 188 of the cDNA from a C to a G
(Genbank REFSEQ: Non-champagne EU432176 and Champagne EU432177), is
predicted to cause an amino acid change from threonine to arginine in the first
transmembrane region of the protein. This may disrupt placement of the transmembrane
portion of the protein in the membrane interrupting function of the ion channel. No
exceptions to the association of this mutation with the Champagne dilution (CH) allele
were identified based on testing 182 additional horses representing 15 breeds, suggesting
that this mutation may be the causative for the dilution phenotype. While this gene is
expected to function as a proton/amino acid symporter based on its sequence and gene
family, this observation for the horse is the first evidence for a phenotypic effect of
mutation of the gene. Identifying this variant also gives breeders a new tool for selecting
breeding stock with or without this dilution genotype.
Extreme lordosis is a condition in which the dorsal to ventral curvature of the
back is accentuated. The condition is considered a conformation fault by many
Saddlebred breeders and is commonly referred to as swayback, softback or lowback.
Previous studies suggested the existence of a hereditary component in American
Saddlebred horses. A whole genome association study was performed utilizing the
Illumina SNP50 beadchip containing over 59,000 SNPs. A 3 Mb region on ECA20 was
found associated with extreme lordosis. The distribution of markers indicated that the
trait had a simple Mendelian recessive mode of inheritance. Subsequently, the
association was confirmed and the region was narrowed to just over 500 kb by a higher
density SNP assay using 47 SNPs selected from the equine SNP database. Identification
of this associated region will allow future studies a better opportunity to locate the
mutation responsible for the lordotic phenotype in young American Saddlebred Horses.
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CHAPTER ONE: Gene Mapping and Current Applications in Horses

Introduction
Genetic tools have been valuable for medical and agricultural research.
Applications of genetics have led to understanding of basic phenotypic variations,
diseases, pathogens and the creation of therapeutic treatments. With the advent of
improved molecular genetic techniques and the completion of whole genome sequences
for many livestock species, including the horse, scientists have uncovered genes related
to diseases, color patterns and performance traits. This dissertation describes two
approaches to gene discovery used to investigate a coat color gene (Champagne dilution)
and a morphological trait (extreme lordosis). The work is a product of modern technology
but has deep roots in the history of genetics.
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Section I: Nature of Natural and Artificial Selection

Natural Selection
In the middle of the 19th century, Charles Darwin, an English naturalist, noted that
organisms within a species possess individual differences which are less pronounced in
populations living in confined regions, but exhibit more pronounced variations between
populations of different regions, especially with differing environmental pressures
(Darwin, 1859). Inherited variation and evolution had long been recognized before
Charles Darwin published his book On the Origin of Species, but he recognized natural
selection as the subtle, but powerful, force that joined these two observations. Darwin
did not know how genetic variation originated but he recognized that when it occurred,
resulting differences enabled some individuals in a population to be more efficient in
obtaining food and reproducing. Those individuals would leave more offspring leading
to an increase in that genetic variant in future generations. He proposed that changes in
the environment and changes in genetic variation could lead to evolution of new species.
Variables in nature were the driving force of selection. One of his examples is the
difference among beak functions and sizes possessed by finches populating different
isolated islands of the Galapagos archipelago. He deduced differences such as these were
under selective pressure from the environment and must have conferred reproductive
advantage in order to get passed on from one generation to the next generation (natural
selection).
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Artificial Selection
One of the major arguments that Darwin advanced about the power of natural
selection was derived from observations of artificial selection (Darwin, 1859). Artificial
selection exemplified by plant cultivation and animal domestication in which people
select for plants and animals that have desirable traits. Over time, artificial selection has
led to production of wheat with higher yields, faster growth in livestock and greater
power and speed among horses. Farmers select the most phenotypically desirable
individuals for reproduction of the next generation, leading to varieties distinct from
those found in nature, but are superbly adapted to agricultural use. This continued desire
to reproduce desirable traits and avoid undesirable ones for efficiency and profitability is
a driving force behind continued advances in molecular technologies and research.
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Selective Pressure
Selective pressure can be the result of natural selection in the wild, such as the
female mocking bird’s selection of a mate depending upon his song or ecological
selection caused by a trait making an individual more fit for reproduction in a particular
environment. This pressure can also be the result of artificial selection as described
above. Disease causing genes can be under selective pressure within certain populations.
Genetic variants can be subjected to negative and positive selection at the same time. If
the selection pressures are equivalent, then the genes are said to be under balanced
selection and the variant will be maintained in the population.
The genetics of thalassemia, a microcytic anemia, is a good example of how
selective pressure can result in fixation of an otherwise abnormal gene in a population.
The genetic variant α-thalassemia has been found in a uniformly high frequency in Tharu
people of Southern Nepal. Most Tharu people are homozygous for the α-/α-genotype,
with an overall α-thal gene (α-) frequency of .8 in the population. It is suggested that
holoendemic malaria resulted in preferential survival of people with α-thal genetic
variant, enabling this population to survive for centuries despite the high occurrence of
malaria (Modiano et al., 1991). Higher frequencies of the genes for sickle cell anemia,
Glucose-6-phosphate dehydrogenase deficiency and Hemoglobin C are also associated
with selective pressure from malaria in areas of Africa and around the Mediterranean
region (Allison 1954; Ruwende and Hill, 1998 and Agarwal et al., 2000).
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Section II: Discrete Nature of Genes

Gregor Mendel, an Augustinian friar and Austrian scientist, established that the
inheritance of particular traits in peas followed set patterns. He studied traits that were
easy to characterize and only occurred in one of two forms; such as; yellow or green
seeds, tall or short stems, white or purple flowers. He proposed that traits are passed on
from parent to progeny as descrete units (later called genes). He characterized these genes
as being dominant or recessive; dominant genes were always expressed in at least one
parent while recessive genes would not be expressed unless two copies were present; one
inherited from each parent. His work led to two major conclusions. First, one of the two
genes in a parent is passed to its offspring (Law of Segregation). Second, genes for
separate traits are passed on to offspring independent of one another (Law of Independent
Assortment) (Mendel, 1866). These basic principles of genes and heredity were
reestablished independently by three scientists around 1900 (deVries, 1890; Correns,
1900; von Tschermak-Seysenegg, 1900-1901) who are collectively credited with
rediscovery of Mendel’s Laws of Independent Assortment and Segregation.
As an interesting side note, during this same period, the presence of chromosomes
in the cell nucleus was noted by cytologists including Walther Flemming, Wilhelm von
Waldeyer-Hartz and Edouard Van Beneden (Flemming, 1878; Waldeyer-Hartz, 1888).
After the turn of the century, the relationship between chromosomes and heredity was
first suggested by Theodor Boveri and expanded upon by Walter Sutton (Sutton, 1902).
Morgan (1910) proved that chromosomes are the source of hereditary material.
Mendel’s basic laws of heredity are the foundation of current studies to identify
the genes responsible for simple and complex traits. During the 1900s many Mendelian
genes were uncovered, one of the most famous being the ABO blood group system. In
1900, Karl Landsteiner identified four blood types A, B, AB and O in humans; however
the specific genetic basis underlying the ABO system was not described until 24 years
later (Bernstein 1924)
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Modes of Inheritance
The mode of inheritance is the manner in which a gene and its corresponding
phenotype are passed down from one generation to another. Modal inheritance patterns
can be categorized as follows; autosomal dominant, autosomal recessive, X-linked
dominant, sex-linked, complex and mitochondrial. (Autosomes are the chromosomes
that occur in duplicate pairs in individuals, one coming from each parent; Sex
chromosomes are the X and the Y chromosome that determine the gender of the
individual.) Autosomal dominant genes are always phenotypically expressed when
present, whether occurring as a singleton or in duplicate. If the gene has a different effect
when present in two copies, then it is referred to as an incomplete dominant gene. Cream
dilution in horses has an incomplete dominant mode of inheritance as shown by the
dilution of brown pigment when present in one copy and dilution of all pigment when
present in two copies (Adalsteinsson, 1974). Autosomal recessive conditions are only
manifested in individuals bearing two copies of the variant allele, or, to put it another
way, in the absence of a dominant gene. Chestnut coat color is due to a recessive gene
resulting in a loss of function variation that prevents production of black pigment
(Marklund et al., 1996).
Sex linked inheritance is associated with genes on the X or Y chromosome in
mammals. Females have two copies of the X chromosome while males have only one X
and one Y chromosome. Males possess a single copy of genes on the X chromosome and
will express whatever gene is present. As a consequence, genes which are recessive and
rarely detected in females are readily expressed in males. Males are said to be hemizygous for the X chromosome since they have but one copy. X-linked recessive traits are
manifested in females where both X chromosomes bear the variation and in males
carrying just the single X chromosome with the causative variation. Hemophilia is a
hemorrhagic disease inherited as a sex linked recessive trait. Queen Victoria of England
was a carrier of hemophilia. It was long speculated which form of hemophilia was
carried by the royal family and no living carriers exist. Discovery of tombs containing
Czar Nicolas II’s entire family provided the necessary genetic material, namely from
Czar Alexis who had the disease. This led to the discovery that the royal hemophilia was
hemophilia B caused by a mutation of the F9 gene (Lannoy and Hermans, 2010)
6

Some phenotypically similar traits have heterogeneous origins, with different
genetic variations within the same gene responsible for a common phenotype, such as is
the case with Dominant White in horses. In some horse breeds all white or partial white
horses arise from the matings of solid colored parents. In many of these cases the white
color is inherited as a monogenic autosomal dominant trait that spontaneously arose in
one of the parent’s germ line cells (Haase et al., 2007, Haase et al., 2009, Haase et al.,
2010). Duchenne’s muscular dystrophy (Emery, 1984) is the result of many different
individual variations, some of which occurred spontaneously in germ line cells. Genetic
variations in different genes can also cause a single phenotype. Osteogeneisis imperfecta
(OI) is a connective tissue disorder with different genes (namely collagen gens and genes
coding for proteins that form complexes with them) responsible for different types of OI.
Complex inheritance is the result of multiple genes, their interactions with other
genes and/or interactions with the environment, all playing a role in the risk of disease or
trait development. Athletic performance is influenced by training in addition to
hereditary characters influencing strength, endurance, speed and intellect. For example: a
287 bp in/del identified in the angiotensin converting enzyme, ACE gene, was found to
be associated with serum levels of the product enzyme (Rigat et al., 1990). Frequency of
the insertion allele was also found to be associated with endurance 1996 study of
Australian rowers (Gayagay et al., 1998). In a study of British mountaineers, the ACE
insertion allele was associated with the ability to climb greater than 8000 feet without
oxygen with no deletion homozygotes present in this elite group. The deletion genotype
has been found to be associated with sprinters and short distance swimmers (Montgomery
et al., 1998). Observed associations such as this only account for part of the heritability
of these traits. There are other yet unknown genes involved in these abilities or
phenotypes.
Mitochondria are organelles found in the cytoplasm of cells; mitochondrial DNA
is a closed circular molecule 16,569 bp long, encodes 13 genes and is only inherited from
the mother (Anderson et al., 1981, Giles et al., 1980). Many of the inherited
mitochondrial disorders are due to mutations in the approximately 1500 nuclear genes
that are targeted to the mitochondria and only half of which have been identified (Calvo
et al., 2006).
7

Linear Organization of Genes and Recombination
The first linkage between genes was discovered, but not understood, in studies of
dihybrid crosses in pea plants similar to Mendel’s work, by William Bateson, Edith
Rebecca Saunders and Reginald Punnett (Bateson et al., 1905). This linkage between
traits was later elucidated by Thomas Hunt Morgan in his studies of Drosophala
melanogaster (fruit flies) at Columbia University. Morgan ascertained the presence of
the discrete hereditary sex determining unit known as the X chromosome in breeding
experiments with a white eyed fly (Morgan, 1910). He observed co-segregation of white
eyes and gender corresponded with the presence of chromosomes. Morgan suspected
crossing over/recombination of chromosomes when he noticed that the “linked” traits of
small wing and white eye would sometimes separate (Morgan, 1911). Morgan’s student,
Alfred Sturtevant, was able to calculate the linear genetic relationship between the trait
loci and piece together the first map of genetic linkage by calculating recombination
frequency/crossing over events between linked loci (Sturtevant, 1913). This research
demonstrated that genes were discrete hereditary units which were joined in a linear
arrangement in relation to one other like beads on a string (Sturtevant and Beadle, 1939).
Some chromosomes are very large and it is not possible to detect linkage between genes
residing on opposite ends of a chromosome. Therefore, the presence of testable markers
that give good coverage of a chromosome is important.
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Section III: Nature of Genetic Variation
Every cell of mammals, except germ line cells, contains the full complement of
DNA, called the genome. Its code is comprised of different combinations of only four
bases; adenine, thymine, guanine, and cytosine (A, T, G, C). Phenotypic differences in
organisms are the result of physical and structural changes to this code. There are also
many physical and structural differences of the DNA that will not be associated with
phenotypic differences. These variations present in the genome are discussed below.

SNPs
Single nucleotide polymorphisms, SNPs, are a single base change in the sequence
of DNA. In 2001 a human SNP map was compiled using 1.42 million SNPs. This
included all the SNPs that were publically available from multiple sources in November
of 2000. This indicated about one SNP per 1.9 kbp. An estimated 60,000 of these SNPs
were believed to fall within coding regions (Sachidanandam et al., 2001). By 2008, a
sequencing project of an individual person identified over 3 million SNPs. This indicates
the presence of approximately 1 SNP per 1000 bases. More than 10,000 of the SNPs
cause amino-acid substitutions in known coding sequences (Wheeler et al., 2008). The
number of SNPs present in the genome can vary among other species, as the grapevine
(Vitis vinifera L.) has SNPs occurring one in every 47 bp in non-coding regions and one
in 69 bp in coding regions (Lijavetzky et al., 2007)

Insertions and Deletions: In/Dels
Insertions and deletions (IN/DELS) can involve a single base or several thousand
bases and have the potential to cause disease or phenotypic change if they occur in a
location that alters a gene’s transcript or expression. Messenger RNA transcripts are read
by the translation machinery in sets of three base pairs at a time, called codons. The
insertion or deletion of a single base, or any group of bases not in a multiple of three,
results in a “frameshift”. A frameshift results in a different codon reading frame from the
point forward from a mutation resulting in an altered product or introducing a premature
stop codon.
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Duchenne’s (DMD) and Becker’s (BMD) Muscular Dystrophy are examples of
genetically heterogenous X-linked recessive lethal diseases caused by various deletions,
duplications and point mutations in the dystrophin gene. The dystrophin gene is a large
gene coding for a long protein product that is part of the motor network in muscle cells.
Disease severity depends on whether the in/del creates a frame shift or remains in frame.
The frame-shift variants cause a more severe phenotype, because the altered reading
frame introduces premature termination codons, whereas in frame variants are still
functional (Prior and Bridgeman 2005). The dystrophin gene is located on the X
chromosome in a highly morphogenic region, also known as a mutational “hot spot”.
Deletions or duplications account for about two-thirds of the cases of DMD and BMD
with the remainder of the cases accounted for by smaller deletions and point mutations as
reviewed by Prior and Bridgeman (2005).

Tandem Repeats
Tandem repeats are categorized into two groups; micro- and mini- satellites.
Microsatellites can range from 1 to 4 base pairs; single nucleotide, dinucleotide
trinucleotide and tetranucleotide. Repeats of units 6 to 64 bases long are minisatellites
and can span from 100 bp to 10 kb (Jeffries et al., 1985). Satellites are units from 5 to
171 bp and repeats can span from 100 kb to several Mb. A mega satellite is a repeat
composed of units several kilobases long and can span several hundred kilobases. The
number of repeats in succession can be polymorphic in the population due to polymerase
slippage at DNA replication or mismatched recombination during meiosis.
Microsatellites in the form of simple tandem repeats with the dinucleotide
sequence [i.e., (dT-dG)n], are interspersed throughout the human genome with
approximately 50,000 copies present. They can be highly polymorphic and their
variability makes them suitable for gene mapping and parentage testing (Litt and Luty
1989, Weber and May 1989). They are usually absent from exons of genes because a
dinucleotide expansion would disrupt the reading frame of the exon in which they
resided, resulting in a frame shift. Polymorphism of a dinucleotide repeat in the STAT 6
gene is associated with allergic diseases (Tamura et al., 2001). Trinucleotide repeats are
the most common form responsible for repeat expansion diseases and disorders.
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Huntington’s disease, a neuronal degenerative disease in humans, is a genetic
disorder inherited in an autosomal dominant fashion and is caused by an exonic
trinucleotide (CAG)n expansion. In the normal population this repeat is highly
polymorphic ranging in size from 11 to 34 repeats. Huntington’s cases possess 48 or
more repeats of this trinucleotide. Expansions of the repeat occur from one generation to
the next and exhibits “anticipation”, which is an earlier age of onset with each affected
generation due to increased repeat length. Lack of recombination of the affected
chromosome and transmission from the father is typical (HDCRG 1993). Myotonic
dystrophy 1, DM1, is caused by a trinucleotide CTG expansion in 3’ untranslated region
of the dystrophia myotonica-protein kinase gene, DMPK; whereas, an intronic
tetranucleotide CCTG expansion in intron 1 of zinc finger protein 9, ZNF9 is responsible
for dystrophia myotonica 2, DM2 (Liquori et al., 2001).
Minisatellites can be highly polymorphic. A human DNA “fingerprint” was
purified and cloned in 1986. This 6.3 kilobase long minisatellite contained multiple
copies of a 37 bp repeat unit. It was found to have 77 different sized alleles containing 14
to 524 repeats among 79 individuals (Wong et al., 1986). The human Aggrecan (ACAN)
gene contains several repeat domains which are recognition sites for the binding of other
molecules. Its keratin sulfate attachment domain has 11 repeats of a hexameric amino
acid sequence. The chondroitin sulfate binding region, CS1, has a highly conserved
repeat region that translates to the same 19 amino acids repeated 19 times (Doege et al.,
1997). Larger repeats, which are so big they cytogenetically alter the chromosomes, have
been identified. A repeat spanning over 1 Mb of chromosome 15 has been identified.
The repeat region contains unprocessed partial duplicates of the GABRA5 gene and
unprocessed duplicates the immunoglobulin heavy chain (IgH) D segment gene and the
neurofibromatosis type 1 (NF1) gene (Ritchie et al., 1998).
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Transposable Elements
The first transposable elements were discovered in maize (McClintock, 1950).
Transposable elements can be separated into two categories, Class I retrotransposons and
Class II transposons. Class II elements are DNA transposons which are movable elements
that are excised from the genome then inserted at a new location. This family of
transposable elements includes; Drosophila P elements, Helitrons and Maverick (Richard
et al.,. 2008). The Class I elements relocate in a copy and paste method utilizing RNA
as the copy which is then reverse transcribed and pasted back into the genome in another
location. These elements include long terminal repeats (LTRS), long interspersed nuclear
elements (LINES), short interspersed nuclear elements (SINES), Dictyostelium
intermediate repeat sequence (DIRS) elements and Penelope-like elements (PLE). In the
horse, ERE1 and ERE2 are two members of the SINE family of transposable elements
(Gallagher et al., 1999). There are five members of the LINE family of transposable
elements represented in the horse (Adelson et al., 2010).
Alu elements of the SINE category are roughly 280 nucleotides long with no
introns and are the most common transposable elements across the human genome with
nearly 1 million copies present (Schmid, 1998). Alu elements are commonly found
associated with some microsatellites and may play a role in microsatellite expansion or
transposition within the genome (Arcot et al., 1995). The insertion of Alu elements into
or near genes can disrupt gene function. Genetic mutations in genes due to insertion of
Alu elements account for approximately 0.1% of human diseases or disorders including,
but not limited to; neurofibromatosis, hemophilia, breast cancer, Apert syndrome,
cholinesterase deficiency and complement deficiency (Deininger & Batzer, 1999). An
Alu insertion into exon 5 of the Factor IX gene was found to be the cause of hemophilia
B in one patient. This insertion interrupted the reading frame of the gene and introduced a
stop codon within the inserted sequence (Vidaud et al., 1992).
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Copy Number Variations (CNV)
When insertions or deletions involve an entire gene, and possibly its promoter
region, copy number variations arise. An increased or decreased number of the same
gene creates a gene dosage effect. For example, a duplication of the CC chemokine 3-like
1 (CCL3L1) gene has been found to decrease host susceptibility to infection by HIV.
The product of this gene is a ligand for the main co-receptor for HIV, the CC chemokine
receptor 5 (CCR5). Individuals possessing more copies than the population average of
two to four copies (depending upon the geographic region/population) for the CCL3L1
gene have decreased susceptibility to HIV infection. Individuals with the lowest copy
numbers for these populations had between 69 and 97% higher chance of getting HIV
(Gonzalez et al., 2005). Copy number variations have been found associated with autism
(Sanders et al., 2011). A duplication found at a site known for microdeletions, which
cause Williams–Beuren’s Syndrome, has been found to have the opposite effect of the
microdeletions, which are known for expressive language, but poor drawing capabilities.
The patient with the duplication had severe language difficulties, especially with
expressive language, but had increased drawing capabilities for expressing thoughts
(Somerville et al., 2005).

Pseudogenes
Pseudogenes are related to functional genes, but are defective. Pseudogenes fall
into two categories; genes that retain the regulatory and intervening sequences and the
more abundant variety that lacks introns and regulatory sequences. The latter category,
known as processed pseudogenes, are the result of reintegration mature mRNA into the
genome; a process also known as retrotransposition. Processed pseudogenes lack introns
and other regulatory sequences, have poly A tails and are flanked by direct repeats of 717 base pairs (Vanin, 1985). Pseudogenes can complicate gene discovery with their
similarities to functional genes. Beta-tubulin is a member of a multi gene family. Four
sequences are represented in the human genome. One sequence is the expressed gene
which yields 1.8 kb and 2.6 kb mRNAs resulting from two different polyadenylation
sites. The other three members of this family are processed pseudogenes each flanked by
different short direct repeats; two derived from the 1.8 kb mRNA and the other derived
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from the 2.6 kb mRNA (Gwo-Shu Lee et al., 1983). Not all retroposons result in
pseudogenes. The human phosphoglycerate kinase family includes a functional intronless
PK2 gene and the pseudogene psi hPgk-1 (McCarrey, 1990).
Redundancy can be created in a genome when one or several genes or even the
entire genome is duplicated in its entirety. Segmental duplication can happen during
unequal “crossing over” resulting in homologous recombination between similar
sequences. When complete genes are included in the duplicated sequence, the gene
duplication events can lead to growth of gene paralogues. Resulting gene families
contribute to copy number variation and increased gene dosage effect. When mutations
collect in one or more of a gene’s duplicates, they may be silenced into a pseudogene or
become a unique gene with a new distinct or specialized function. Approximately 40% of
the coding regions in the olfactory receptor cluster on human chromosome 17 are taken
up by pseudogenes (Sharon et al., 1999).

Inversions
Inversions are DNA segments that have been flipped compared to their relative
position in the genome. In heterozygotes they have been noted to suppress recombination
of the region in which they reside. An inversion will cause phenotypic effects if it
disrupts a gene or regulatory region that controls expression of a gene or genes.
Many cases of Hemophilia A were found to be caused by an inversion.
Hemophilia A is an X-linked disorder caused by various mutations in the factor VIII gene
(Lakich et al., 1993). Approximately 43% of individuals with this disease possess an
inversion involving this gene due to chromosomal homologous recombination beginning
mainly in male germ cells (Antonarakis et al., 1995). In horses, a 43Mb inversion near
the KIT gene has been found responsible for the Tobiano coat pattern (Brooks et al.,
2007).

Translocations
Mismatching during meiosis can lead to translocations where one segment of a
chromosome is removed from its normal location and moved to a different position on
that chromosome or to another chromosome. Large translocations are usually
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microscopic in size and categorized as cytogenetic defects. Smaller translocations have
to be characterized on a molecular level. Autosomal translocations, characterized
cytogenetically, have been associated with repeated early embryonic loss in horses (Lear
et al., 2008). Translocations of genetic material from the X or Y chromosomes can have
developmental effects on sex determination (Villagómez et al., 2011). Examples of
human diseases caused by translocations include acute myeloid and acute lymphoblastic
leukemia. In these diseases the Myeloid/Lymphoid (MLL) gene has been implicated
because it spans the breakpoint of an 11q23 translocation (Thirman et al., 1993).

Methylation/Imprinting
The methylation status of any genomic region can determine whether that region
is packaged tightly into heterochromatin and transcriptionally silenced or whether it is
more loosely packed into euchromatin exposing it to molecular factors for its active
transcription. The methylation status of some regions or genes can be maternally or
paternally predetermined at conception, a phenomena known as imprinting. The hybrid
offspring of horses and donkeys are known as hinnies (product of female donkey male
horse) and mules (product of female horse and male donkey). Their physical and
temperamental differences are suspected to be the result of preferentially expressed
maternal/paternal genes (Allen et al., 1993). Hinnies tend to be smaller in stature like the
donkey dam and have longer manes and shorter ears like the horse sire. Mules tend to be
taller like the horse dam with longer ears and sparse mane more like the donkey sire.
Both tend to have temperaments more similar to the sire as well. In a recent study
comparing, horses, donkeys, mules and hinnies, it was found that 15 known imprinted
genes, play a major role in placental development. These 15 equine imprinted genes
matched imprinting direction as previously seen in human, mouse, hinny and mule. The
five maternally expressed genes included insulin-like growth factor 2 receptor (IGF2R)
and nucleosome assembly protein 1-like 4 (NAP1L4). The ten paternally expressed genes
included Insulin-like growth factor 2 (IGF2) and paternally expressed gene 3 (PEG3).
An additional 78 paternally biased candidate imprinted genes were also identified (Wang
et al., 2013). The different prenatal environments resulting from these differentially
expressed genes may explain a few of these differences.
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There are some genes that are dosage dependent and one active copy is all that is
required for development and life. Two active copies may result in a disease state. To
protect against this, one copy, the mother’s or the father’s (depending upon the gene), is
silenced by methylation of cytosines in GC rich regions within that genomic area. These
genes are inherited from the mother or the father in a silenced or active state known as
imprinting. The insulin like growth factor 2 (IGF-2) gene is affected by tissue specific
maternal imprinting in mice. Both alleles are transcriptionally active in the choroid
plexus and leptomeninges, but only the paternal IGF 2 allele is active in all other
embryotic tissues (DeChiara et al., 1991). Genes may also be silenced or activated by
increased or decreased methylation due to environmental cues or point mutations that
alter the GC content of a region. The changes to DNA methylation or histone acetylation
as a result of exposure to carcinogens is implicated in some cancers by the mechanism of
increased methylation of DNA repair genes or deacetylation of histones allowing
reactivation of developmental genes, both of which may possibly also be a catalyst for
increased mutation rate of surrounding DNA or destabilization of nearby microsatellites.
Excessive methylation throughout a 5' "CG island" region of the pi-class glutathione Stransferase gene (GSTP1) is associated with human prostate cancer (Lee et al., 1997).

Heterogeneity of Phenotypes
Not all phenotypes are the result of single discrete Mendelian variation. There are
some diseases with well defined phenotypes that are caused by different variations in
different families or populations, but within the same gene. Alternately, there are diseases
with similar, yet difficult to distinguish, phenotypes which can be the result of variations
in different genes that play roles in the same pathway or process. Severe combined
immunodeficiency (SCID) is a group of autosomal recessive diseases in people that is
genetically and phenotypically heterogeneous. Two of the first phenocopies of SCID
characterized in the 1970s were purine nucleoside phosphorolase deficiency and
adenosine deaminase deficiency both of which are inherited in an autosomal recessive
manner (Giblett et al., 1975, Giblett et al., 1972 and WHO Scientific Group, 1995). Xlinked forms of SCID are due to mutations in the γ chain of IL-2 receptor (Schwaber and
Rosen, 1990). The more rare causes of SCID are the result of MHC class II deficiency,
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reticular dysgenesis, CD3γ or CD3ε deficiency or CD8 deficiency (Reith et al., 1988,
Ownby et al., 1976,). There is heterogeneity of variants within the genes responsible for
each type of SCID. SCID is a condition in horses and mice, but equine and murine SCID
are a result of a deficiency in DNA-PK; a gene not implicated in any cases of human
SCID(Perryman and Torbek 1980, Pla and Mahouy 1991).
Cystic Fibrosis (CF) is an autosomal recessive disease that is the result of many
different individual mutations in the CFTR gene. Several of the variations responsible for
CF and differences between their manifestations of the disease are covered in a review by
Lommatzsch and Aris (2009). The CFTR locus was mapped by positional cloning to
human chromosome 7q in 1989 and was the first genetic disease mapped in this fashion
(OMIM 1998). This disease has a broad range of manifestations depending on the
mutation(s) present in the individual. Generalized atrophic benign epidermolysis bullosa
(GABEB) is another autosomal recessive disease responsible for sub-epidermal
blistering, alopecia, dystrophic nails and dysplastic teeth which is caused by different
independent mutations in the same gene. This disease is due to reduced or eliminated
expression of the collagen17 gene, COL17A1 also known as BPAG2, resulting from
nonsense mutations, which are genetic variations that introduce premature stop codons
(PTCs) into a transcript. A few of the mutations responsible for GABEB are SNPs
altering an amino acid residue directly to a PTC (Darling et al., 1997). Another causative
variation is in the form of a double base deletion which creates a frame shift in the
reading frame of the resulting RNA creating a PTC downstream of the deletion (McGrath
et al., 1996). These variations each cause disease when an individual is homozygous for
any one, but individuals can also be affected when they are compound heterozygotes
(Darling et al., 1997). Fragile-X Syndrome, hemophilia, Duchenne’s and Becker’s
Muscular Dystrophy and red-green color blindness are other examples of X-linked trait
with heterogeneity of mutations within a single gene.
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Complex Genetic Modes of Inheritance
Many common traits and diseases are not the result of simple Mendelian
inheritance of a single variant. These are defined as quantitative traits that result from the
cumulative action of multiple genes that interact with each other in a biological pathway
or process. Causative genes identified in the study of complex traits are known as
quantitative trait loci (QTLs). In humans, height clearly has a genetic component but is
the product of many genes, deduced from early genetic studies over 95 years ago (Galton,
1886, Fisher, 1918). Heritability of height is approximately 0.8, meaning it has a very
strong genetic component, but roughly 20% of height is determined by environmental
factors (Visscher et al., 2010, Allen et al., 2010). Hypertension (high blood pressure) is
a common disorder that is the result of complex polygenic inheritance (Rapp, 1983).
Hypertension can lead to stroke, heart attack or other forms of cardiovascular disease.
Cardiovascular disease is the leading cause of death in the world (WHO, 2011). Initial
investigations to locate QTLs for hypertension were done crossing hypertensive rat
strains with normotensive strains then crossing the F1 progeny to produce offspring to be
tested for segregating marker alleles (Rapp, 1983; Rapp, 1987 and Rapp, 1991).

Milk yield, fat percentage, fat yield, protein percentage and protein yield are
polygenic traits in dairy cattle. These traits are the consequence of the interaction of
multiple genes and are partially affected by environmental factors. The first statistically
significant QTLs for milk production in Holstein dairy cattle were mapped to five
chromosomes implementing interval mapping and “progeny testing” using microsatellites
(Georges et al., 1995).

Osteochondrosis dissecans (OCD) is a condition in horses where the bone under
the articular cartilage fails to completely form resulting in tears and fissures in the
cartilage surface above and can affect any bone/joint surface. It can affect the cartilage of
any joint, but clinical significance is attributed to joints that affect soundness.
Heritablility for Osteochondrosis of the hock joint (OC) and palmar/plantar osteochondral
fragments (POF) was investigated in a study that included 24 Swedish Standardbred
trotter sire families. This study concluded a heritability of 0.34 for OC and 0.23 for POF
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(Philipsson et al., 1993). It is thought that several genes play a role in location and
severity, as well as its age of onset. There appears to be an increased occurrence of this in
young horses with rapid growth. This condition is considered to be a complex trait and it
is believed diet, injury, exercise and genetics all contribute to its development
(Stromberg, 1979). Microsatellite based WGAS conducted over the last decade have
identified 14 quantitatitive trait loci that play a role in OCD, but only a few match
locations between the different breeds of horse (Distl, 2013).
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Section IV: Genetic Markers and Maps
The rediscovery of Mendel’s genetic principles led to investigations for
Mendelian genetic variation in diverse organisms. For example, this led to investigations
of blood groups in animals such as; cow (Ferguson, 1941), pig (Andresen and Baker,
1964) and horse (Stormont and Suzuki, 1964). Biochemical and isozyme alleles were
found to be valuable and potentially polymorphic markers to observe for hereditary
variation between individuals. Isoenzyme markers also became useful biochemical
markers for certain malignancies (Bostick et al., 1978).
During the 1970s, scientists were sequencing the genes they identified. Some of
the first sequencing was accomplished through chemical modification of the DNA and
cleavage of the modified product at Harvard University (Maxam and Gilbert, 1977). The
development of the chain-terminator sequencing method designed by Frederick Sanger at
Cambridge University was a groundbreaking step in molecular genetics (Sanger and
Coulson, 1975 and Sanger et al., 1977). Higher sequencing throughput increased the
discovery rate of polymorphisms in the genome such as SNPs and microsatellites.
Restriction fragment length polymorphisms, RFLPs, are the result of polymorphisms in
the genome that introduce or eliminate a cleavage recognition site for restriction
enzymes. Restriction enzymes are a special class of bacterial endonucleases that
recognize specific sequences of nucleotides in double stranded DNA and cause cleavage
of both strands in a specific place of the recognition site. Their original function was to
degrade bacteriophage DNA to restrict its ability to proliferate in the bacteria. The first
specific cleavage site was found for the restriction endonuclease Hae I (Kelly and Smith,
1970). Sites for these enzymes were some of the first markers used for mapping purposes
(Botstein et al., 1980). An initial linkage map of the human genome was developed in
1989 with 403 polymorphic loci, including 393 RFLPs linked to approximately 95% of
the genome (Donis-Keller et al., 1987). Sickle Cell Anemia, an amino acid variant in
hemoglobin resulting from a single base change, was the first instance of a disease
phenotype found to be linked to a polymorphism at a restriction site (Kan and Dozy,
1978). The gene for Huntington’s disease was mapped to chromosome 4 and the region
where it resided was narrowed considerably using RFLPs (Shoulson and Chase, 1975,
Gusella et al., 1983, Gilliam et al., 1987). Restriction sites contain only two alleles, so
20

RFLPs aren’t always sufficiently informative for mapping endeavors. The more
polymorphic nature of microsatellites made them a new valuable tool for gene mapping
and parentage testing (Litt and Luty, 1989, Weber and May, 1989). A second generation
linkage map was constructed using family segregation analysis, with 813 markers on 22
autosomes and the X-chromosome spanning regions covering about 90% of the estimated
length of the human genome (Weissenbach et al., 1992). Over the next two years, the
human marker map would be expanded to 2,066 markers (Gyapay et al., 1994)
In 1990, the NIH gene-mapping project, also known as the human genome
project, was initiated. What began in 1911 with the assignment of a single gene on the
X-chromosome became the project of the century in 1990, a 15 year plan with the end
goal of sequencing the entire 3 billion base pairs of the human genome. This project,
which seemed farfetched at its inception, was completed 2 years ahead of schedule in
2003. A press conference on April 14th of that year and special issues of Nature: Double
Helix at 50 (April 24, 2003) and Science Building on the DNA Revolution (April 11,
2003) marked this historic landmark in genetic research.
The human genome of approximately 3 billion base pairs was sequenced and
subsequently assembled in 2001 to find that it actually only harbors 20 to 25 thousand
genes (Venter et al., 2001, International Human Genome Sequencing Consortium 2004).
To explain human complexity from so few gene products, it is believed that about 70% of
human genes produce multiple mRNAs from alternate splicing of exons or parts of exons
(Black, 2003). A single gene can produce multiple mRNA and/or protein products. Each
gene product can affect multiple genes upstream and downstream from it or even affect
its own transcription with positive or negative feedback. A common phenotype can arise
from multiple variations in a single gene or from variations in a variety of genes within a
network. Different variations in a single gene can play a role in many phenotypically
different traits or diseases or be the cause of a single disease or phenotype. Even
environmental factors can affect gene expression or even result in the introduction of
variations which lead to disease phenotypes.
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Genome Sequences and SNP Discovery
The Human Genome Project ushered in an era of genomics with the development
of methods and tools to cheaply and rapidly sequence DNA and investigate gene
expression. With the advent of the genomics era, the complete genomes of more than
180 organisms have been sequenced
(http://www.genomenewsnetwork.org/resources/sequenced_genomes/genome_guide_p1.
shtml). The genomes of pathogens have been sequenced to aid in the development of
vaccines and therapies; Neisseria meningitidis, Heliobacter pylori, Mycobacterium
tuburculosis and Pseudomonas aeruginosa (Pizza et al., 2000; Tomb et al., 1997; Cole et
al., 1998 and Stover et al., 2000) to name a few. The genomes of model organisms;
Drosophilia melanogaster (Adams et al., 2000; Myers et al., 2000; Rubin et al., 2000),
mouse (Asif et al., 2002) and Norway rat (Gibbs et al., 2004) were sequenced to inform
us about genetics, The genomes of many vertebrates, including cattle (Zimin et al., 2009),
chickens (Hillier et al., 2004)), dogs (Lindblad-Toh et al., 2005)) and horses (Wade et al.,
2009), were sequenced to inform us about the genome organization of vertebrates relative
to that of human and mice.
This surge of DNA sequencing led to discovery and use of SNPs which are, at
best, only diallelic and often may not be polymorphic in families or even in certain
populations. However, these are so numerous that finding a polymorphic SNP within a
region is relatively simple since they occur roughly 1 per 1000 bases. Genome-wide
studies identify millions of SNPs from which assays of tens of thousands would provide
coverage of 20 or more SNPs per centiMorgan. For example; the low density SNP array
currently used for the domestic horse includes over 54,000 polymorphic SNPs with
approximately 54kb between SNPs (McCue et al., 2012). SNPS can and are used for
linkage studies, but the large numbers available make them suitable for genome wide
association studies (GWAS), which have power for the mapping and discovery of genes
responsible in complex traits and diseases (International Hapmap Consortium, 2007).
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Nature of Genome Wide Association Studies (GWAS)
A genome wide association study is a way to investigate genetic associations at a
population level without families. This is necessary if the trait is rare, samples are
difficult to acquire or if the mode of inheritance is unclear. The discovery of more than a
million SNPs and the ability to design and implement a SNP chip to assay thousands of
SNPS spanning the entire genome at the same time has provided a way to perform
powerful population level studies. A genome-wide association study (GWAS) is the
investigation of thousands of common genetic variants in different individuals in search
of any variant associated with the trait of interest. It is based on the concept of linkage
disequilibrium, LD, shown in Figure 1.1. Variations in the genome arise over time. All
individuals possessing the variation also share a common set of markers, some of which
are close enough to the variation that they were passed down together from generation to
generation. In a GWAS, informative markers in LD with the variant or gene of interest
will show statistical significance.
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Figure 1.1: Linkage Disequilibrium Explained.
This figure shows the emergence of variations over time. The red starburst is a genetic
variation of interest. This is an example of linkage disequilibrium (LD) between a
specific variant and nearby markers/variants. The variation of interest is closer in time of
emergence with the brown marker, but physically closer and in LD with the white
marker. This physical proximity reduces the likelihood these two points will be separated
by recombination during meiosis.
The completion of whole genome sequences and discovery of millions of SNPs
has made it possible to investigate genetic associations at a population level and without
involvement of families. This is important in the following cases:
•

The trait is rare and a limited number of affected individuals are available for
study,

•

The trait is one which is undesirable and breeders will not select or save affected
offspring, (Indeed, in extreme cases they may be reluctant to identify affected
offspring as coming from their breeding stock.)

•

The mode of inheritance is unclear, due to genetic complexity or due to
incomplete penetrance.
In such cases, GWASs have proven effective by successfully identifying risk loci

for disorders such as rheumatoid arthritis, Crohn’s disease, bipolar disorder,
hypertension, diabetes and many others (Stranger et al., 2011). GWAS is based on a
basic population genetics concept, the presence of linkage disequilibrium between genes
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and markers. Animals which belong to the same breed may share common ancestors
within 10, 20 and 30 generations spanning 100-300 years. Genes closely linked in the
ancestor are unlikely to have been separated by genetic recombination events. As a
result, there will be a statistical association between alleles of closely linked loci. In
practice, human populations demonstrate linkage disequilibrium between SNPs in
haplotype blocks that are from 8.8 to 25.2kb (Hinds et al., 2005). For horses, dogs, and
cattle, the LD ranges from 1-8 million bases (McCue et al., 2010; Gray et al., 2009 and
Khatkar et al., 2008). Therefore, when a genetic trait exists within a population and
animals with and without that trait are compared, using tens of thousands to hundreds of
thousands of informative SNPs, statistical associations may be detected.

Marker Maps for Linkage Studies, Especially in the Horse
With the advent of molecular genetics, several types of genetic markers were used
in early linkage studies. The two earliest markers used were restriction fragment length
polymorphisms (RFLPs) and simple tandem repeats (STRs) or microsatellites. RFLPs,
were used to develop genetic maps in hybrid plant lines (Tanksley et al., 1989) and for
domestic animals (Fries and Ruddle, 1989). Microsatellites soon proved even more
effective than RFLPs since they were more widely distributed throughout the genome
than STRs and often had multiple loci ensuring that more loci would be informative in
families (Litt and Luty, 1989; Weber and May, 1989). Linkage maps were developed for
many of the organisms being studied. By 1992, a second-generation human linkage map
was constructed of 814 polymorphic markers including microsatellites and RFLPs which
covered about 90% of the estimated length of the human genome (Weissenbach et al.,
1992).
Early studies of genetic markers in horses involved investigations of genetic
systems useful for parentage testing. Three autosomal linkage groups were discovered
prior to the initiation of the Horse Gene Mapping Workshop in 1995. The first linkage
group included the K blood group locus and the 6-phosphogluconate dehydrogenase
locus (Sandberg, 1974). The second linkage group consisted of four loci; serum albumin
locus (Al), tobiano (TO), vitamin D binding protein locus (Gc) and the serum esterase
locus (Es) (Trommershausen-Smith, 1978; Sanberg and Juneja, 1978; Weitkamp and
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Allen, 1979). The third linkage group included the A blood group and lymphocyte
alloantigens (Bailey et al., 1979). The coat colors chestnut and roan were found to be
linked to loci Al and Es in the second linkage group (Andersson and Sandberg, 1982).
Identification of these linkage groups was the beginning of the budding equine marker
map. These discoveries were less an effort to make a comprehensive map and more a
byproduct of genetic investigations.
In the 1990s, microsatellite DNA markers were identified and found to be suitable
for parentage testing (Litt and Luty, 1989; Weber and May, 1989). Over the next decade,
sequencing of equine genes and genomic regions began yielding more and more
microsatellites to be used in a future equine marker map and well suited for parentage
testing
In 1995, a group comprised of 70 scientists from 20 countries gathered to
collaborate on mapping and sequencing the horse genome. Publication of the first
sizeable equine linkage map occurred in 1998 and was comprised of 100 markers in 25
linkage groups encompassing 18 equine autosomes (Lindgren et al., 1998). The next
year, a map was published containing 182 microsatellites and 58 random amplified
polymorphic DNA (RAPD) markers sorted into 33 linked groups. Twenty two of the
groups were assigned to known chromosomes with the remaining 11 groups just
provisionally placed upon verification by other methods (Shiue et al., 1999). The first
linkage maps for horses were reported with 140, 161 and 353 microsatellite markers,
respectively, by combining of resources from the International equine gene mapping
workshop culminating in a comprehensive map of 766 markers (Lindgren et al., 1998;
Guerin et al., 1999; Swinburne et al., 2000 and Penedo et al., 2005).
While linkage maps were effective at identifying genetic distances between
polymorphic genetic markers, they did not provide as much information about genes.
Gene sequences are highly conserved among species and comparative genetic studies
using cross-species fluorescence in situ hybridization (Zoo FISH) indicated strong
conservation of genome structure. Radiation hybrid maps were used to visualize the
relationship of particular genes and markers across species. A comparative horse map
comprised of 4103 markers made up of microsatellites, known genes, and radiation
hybrids of markers from other species was compiled in 2008 (Raudsepp et al., 2008). An
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entire genome reference sequence was still the final goal. A complete assembled genome
sequence would be the most complete marker map compiled, with SNPs, microsatellites
and known genes from comparative maps all easily accessible. The whole genome of the
horse was completed in 2006 with the first online reference assembly available in January
2007. The final assembly was available in September of that same year. The manuscript
detailing sequencing and assembly of the equine genome was published in 2009 (Wade et
al., 2009). This publication included characterization of approximately 1 million single
nucleotide polymorphisms (SNPs), the next tool in genetic discovery. The discovery of
large numbers of SNPs spurred the development and implementation of SNP chips for
equine gene discovery and mapping.
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Nature of Linkage Studies
Linkage studies require assembly of families including sires, dams and offspring
and the use of genetic markers that may be linked to the gene under investigation.
Linkage means that the gene and genetic markers are present on the same chromosome
and sufficiently close that genetic recombination will not cause their co-segregation to be
random (50%). When the gene marker and the gene are very close, for example, 5 to 10
cM apart, then small numbers of offspring (20 or less) may be effective in determining a
statistical proof of linkage. If the genetic markers are more distant from the gene, for
example 20-30 cM apart, then a large number of offspring will need to be tested to
distinguish the linkage relationship from random segregation. Informative families are
often difficult to assemble; consequently, it is beneficial to have one or more genetic
markers that are close to the gene of interest. This is a challenge since we do not know in
advance where the gene and gene markers lie relative to one another. The solution is to
have a large number of genetic markers to assure that at least one will be within 5 to 10
cM of the gene of interest. Botstein et al. (1980) suggested that a human linkage map
with 150 evenly distributed genetic markers would be sufficient to ensure that a gene
would be within 10 cM of a marker based on the observation of 3000 cM for the human
gene map. At the time, it was not possible to select genetic markers which would be
evenly distributed and the solution was to map a greater number of genetic markers so
that, by chance, the gene in question would be sufficiently close to a linkage marker.

Family Linkage Studies
Family linkage studies are applied to search for markers in specific genetic
regions which co-segregate with the gene of interest from parent to offspring. This kind
of study requires assembly of families which include sires, dams and offspring. Genetic
markers are used which may be linked to the investigated gene. Microsatellites, also
known as short tandem repeats (STRs), are a valuable resource in this type of study.
Genetic linkage is based on the concept that genes and markers located near each
other on a chromosome are inherited together. The closer genes are to one another the
less likely they are to be separated during meiosis. The base pairs which compose the
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genetic markers, loci and genes are all connected to one another in a linear fashion on
each chromosome, like beads on a string. This linear connection can be broken and
rearranged during meiosis. At the time of meiosis, the paired chromatids (one half of
each chromosome received from the parents) are susceptible to recombination between
them due to crossing over events.
A linkage map consists of genes and genetic markers shown in relation to one
another in terms of recombination frequency are calculated as a distance, cM. A map of
known markers is an invaluable tool used to discover genes responsible for specific
phenotypes or diseases. Linkage mapping is accomplished with a family study where the
recombination frequencies are calculated with a logarithm (base 10) of odds (LOD) score
method (Morton, 1955). The LOD score, represented as Z, compares the probability of
obtaining the data if the two loci are linked to the probability of obtaining the data if the
two loci are not linked. A LOD score of +3 shows that the odds are 1000 to 1 that the
linkage observed did not occur by chance. LOD is calculated LOD = log10 (1- Θ) NR x ΘR
/ 0.5(NR+R), where Θ = number of recombinants(R) / number of recombinants (R) +
number of non recombinants (NR).
For a dominant, co-dominant or partially dominant trait, mapping is
straightforward. A verified heterozygous sire possesses a trait of interest. Assuming that
markers and genes in proximity to each other will be linked, a search of known markers
for one that is linked with the phenotype will give an approximate location for the genetic
region responsible for the trait. The sire will transmit the gene causing the trait of interest
approximately 50% of the time as shown in Figure 1.2, showing a Punnett square using
Cream inheritance as the example.

29

Figure 1.2: Incomplete Dominant Punnett Square Example: Cream Dilution.
Palomino sire’s genotype CR/cr. He will pass on CR 50% of the time. This Punnett
square uses a palomino dam as well with genotype Cr/cr. This mating would produce
Cremello 25% of the time, palomino 50% and sorrel undiluted 25%. This example is
given on the chestnut base color.
A family linkage analysis is performed with data derived from a sire heterozygous
for the well-defined dominant trait to be studied and 10 to 20 of his offspring. Ten is an
adequate number for initial screening sample sets, but 20 or more informative offspring
may be necessary to achieve statistical significance. Significance is calculated using the
LOD score method to calculate the probability that two loci are linked. The LOD score is
calculated as log10 of the Likelihood Ratio (LR): LR = ΘR (1-ΘNR)/0.5N, where the LR is
the likelihood of association divided by likelihood of no association due to free
recombination. Therefore the LOD value or Z = log10 ΘR (1-ΘNR)/0.5N, where Θ =
recombination rate R/ (NR+R), R = number of recombinants and NR = number of
nonrecombinants.
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Linkage Analysis: Dominant Traits
For example: A heterozygous sire tested with alleles A and B for a particular
microsatellite marker. This marker would not be considered informative if the sire were
homozygous for a single allele. After testing ten of his offspring, five with sire’s trait of
interest and five without it: four of the five offspring who share the sire’s trait had allele
B; the remaining offspring who shared the trait had allele A. Among the five offspring
not sharing the trait, all five had allele A. This data is shown below in the bottom half of
figure 2.6. In this case, all 10 offspring were informative, meaning there was no
ambiguity about which genotype they received from the sire. Offspring are considered
uninformative if they have the same two markers as the sire, because it is unknown which
marker they inherited from him. If the genotype of the dam is known as well, then the
origin of the offspring genotype may be clarified. Occasionally, even with the dam’s
genotype, some offspring still may not be informative. The one offspring with the sire’s
phenotype bearing allele A is considered recombinant. This means from 10 offspring
there is 1 recombinant and 9 nonrecombinants, therefore, R = 1, NR = 9. Plugging them
into the formula above will give this; LR = (0.11(1-0.1)9/ 0.510) = (0.1*(0.387)/0.000977)
= (0.0387/0.000977) = 39.62. Therefore LOD = log10 (39.62) = 1.6. What does this
mean? Association results are considered to be significant if the Z value is equal to or
greater than 3. A LOD value of 3 means there is significant evidence for linkage; this
means the odds are 1000:1 in favor of linkage between loci. The LOD value for these 10
offspring was only 1.6. LOD score values are additive. This means LOD scores for
different sire families can be added if each individual sire has an inadequate number of
offspring to attain significance when LOD values of the different families are combined.
So, if a second family is studied and found to have a LOD score of 1.8, then the
combined LOD score will be 3.4 and considered statistical evidence for linkage.
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Linkage Analysis: Recessive Traits
For a recessive trait, a heterozygote is a carrier (not affected). Carriers are
identified by the presence of affected offspring they have produced. They are expected to
transmit the gene of interest 50% of the time, but only affected offspring will be
informative. Unaffected offspring are un-informative because it is impossible to
determine the status of carrier/non-carriers for a yet undiscovered variation. Two or more
affected offspring per carrier are necessary for effective linkage analysis. According to
Hardy-Weinberg equilibrium (HWE), population frequency of the affected allele can be
calculated using the formula p2 +2pq + q2 = 1, knowing also that p + q = 1, where p =
dominant wild type allele and q = recessive variant allele. Frequencies of the different
genotypes are represented by p2, 2pq and q2. In this population the frequency of lordotic
horses was 0.04, and if caused by a recessive gene, the frequency of this phenotype is
represented as q2. Consequently, the gene frequency for affected allele (q) would be 0.2.
By subtraction, the normal allele (p) would have a frequency of 0.8. According to the
HWE equation, unaffected carriers would be present in a frequency of 2pq or 0.32. An
example of population frequencies of genotypes from crosses assuming HWE is given in
table 1.1.

Table 1.1: Recessive Inheritance Example
Sires
Dams

p=

q=

P = 0.8

0.8
pp = 0.64

0.2
pq = 0.16

q = 0.2

pq = 0.16

qq = 0.04

Population frequency of genotypes occurring in crosses assuming HWE. Frequencies are
represented by p2, 2pq and q2. If the frequency of a recessive trait is 0.04 then a
population frequency of the recessive (q) allele can be calculated to be 0.2 using the
formula p2 +2pq + q2 = 1.
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Microsatellites have been successfully used for family studies in horses. For
example, genomic position of the silver (Z) locus was found when significant linkage was
shown between the candidate gene PMEL17 and microsatellite marker TKY284. This
analysis was accomplished in a family study containing a single sire family that included:
1 heterozygous Silver stallion, 34 of his offspring and their 29 dams which were not
silver (Brunberg et al., 2006. The Appaloosa gene leopard complex (LP) was assigned to
a region of chromosome 1 in the vicinity of two positional candidate genes for LP (pink
eyed dilution (p) and transient receptor potential cat-ion channel subfamily M. member
1(TRPM1) using two paternal half sib families containing a total of 47 offspring (Terry et
al., 2004). Several possible causative SNPs (6) were identified after target sequencing of
a 300kb region containing TRPM1 (Bellone et al., 2010). The genetic locus for Sabino 1
(SB1), which causes a white spotting pattern, was determined after a successful family
study involving 3 sires and 27 offspring and 7 dams (Brooks and Bailey, 2005). The
genomic location where the Cream (C) gene resides was identified using a family
consisting of one stallion, 7 mares and 21 offspring (Locke et al., 2002). The C locus
was identified after sequencing the positional candidate gene MATP (Mariat et al., 2002).
Linkage between microsatellite CORO18 and the Grey locus was identified with 7 half
sib Quarter Horse families including 276 offspring and 128 dams (Locke et al., 2002).
The mutant locus was later identified as containing a 4.6kb duplication in intron 6 of the
STX17 gene (Rosengren-Pielberg et al., 2008).
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When to Use Linkage Analysis and What it Might Miss Relative to GWAS
Family linkage studies are applied when sufficient family members are available
for investigation into simple Mendelian traits. Linkage testing requires minimal marker
coverage, about one per 10 to 20 cM and minimal sample numbers of 20-50 compared to
the hundreds to thousands of samples and markers utilized in GWAS. However, a
linkage study can still fail to produce results if markers near the region of interest are not
informative. This could either be due to parental homozygosity of necessary marker(s) or
unresolved offspring genotypes. Even when a study successfully identifies a linked
marker locus, the locus may not show evidence of association in a population of
unrelated individuals. This could be the result locus heterogeneity between family
groups. For example, family linkage mapping identified the genetic region for Sabino
1(Sb1) white spotting pattern in Tennessee Walking Horses (Brooks and Bailey, 2005).
When to Use GWAS and What it Might Miss Relative to Linkage
When enough family members cannot be obtained or when a trait has complex
etiology, GWAS is recommended, as was the case with lavender foal syndrome (LFS).
LFS is a rare recessive lethal trait found in Egyptian Arabian Horses. This rarity
precluded the collection of enough family members to perform a linkage study.
Therefore, GWAS was performed which successfully identified markers in linkage
disequilibrium with the trait from 6 affected samples and 30 unaffected relatives (Brooks
et al., 2010).
Complex traits are difficult to study by linkage as they are more often attributed to
many genes with minor effect rather than a single gene(s) with major contribution.
Minor effects are more readily identified in GWAS case/control population studies that
provide more power in associations of limited effect on phenotype. Complex traits can
be the result of incomplete penetrance due to; gene-gene interactions, environmental
factors or gene-environment interactions. There are still disadvantages involved in casecontrol study designs compared to family linkage studies. They offer no internal check
for genotyping quality. Results for controls may show a departure from Hardy-Weinberg
Equilibrium (HWE), which could be caused by genotyping error, selective
breeding/mating practices, negative selection, population stratification or pure chance.
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The desired reason for departure from HWE would be the genotyped SNP actually plays
a role in the disease or susceptibility or is in linkage disequilibrium with the causal
variation. Other factors that negatively affect outcome include poor genotyping quality
with missing genotypes and population stratification. The issue of population
stratification can be avoided by using a family-based study, as was done in the lordosis
study discussed in chapter 3.
The search for the cause of Osteochondrosis dissecans (OCD) has been
approached from a linkage study standpoint and whole genome association studies with
mixed results. Initially, a family linkage study was performed on Hanovarian
Warmbloods with 14 paternal half sib families in a search for quantitative trait loci (QTL)
using 172 initial microsatellites and 88 additional ones to refine QTLs. QTLs were found
on ECA 2, 4, 5 and 16 and chromosome wide significance for QTLs was noted on ECA
2, 3, 4, 5, 15, 16,, 19 and 21 (Dierks et al., 2007). GWAS involving South German Cold
Blood horses found association ECA 18 (Wittwerc et al., 2009). GWAS/linkage analysis
was done in Norwegian Standardbred Trotters with 162 horses, 80 cases, 82 controls, 22
half sib paternal groups. Two analyses were performed; mixed model analysis and basic
association test. Both identified QTLs on the same chromosomes; ECA 5, 10, 27, 28
(Lykkjen et al., 2010). GWAS in French Trotters concluded associations with GM
(severity) ECA13, HM (Hock location) ECA3, 13, 14 and other (other locations) ECA
13, 15 (Teyssedres et al., 2012). GWAS investigation of osteochondrosis dissecans in
Thoroughbred horses found association on ECA3 (Corbin et al., 2012). These results
have some similarities but vary more than they agree. In each study, the testing was done
on different breeds with different measures and different affected joints considered. The
variation in results might be attributed to the genetic heterogeneity of the condition as
well as differing management practices or jobs each horse performed. Overall, multiple
loci contributing to OCD have been successfully identified by one or more of the listed
studies. A more concise set of parameters regarding the joint affected, severity of lesions
and age of onset may be beneficial for more consistent results between studies and
breeds.
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Section V: Applications of Genetic Tools
The foregoing describes the nature of genetic variation and some examples of
resulting phenotypes. When phenotypic variation is apparent within a population, we
have two major tools for investigation: linkage studies using families and genome wide
association studies using individuals selected from a population merely based on
phenotype. The discovery of microsatellite DNA markers spanning the horse genome
during the last 20 years has made possible genome wide linkage studies when families
are available. The development of the horse genome sequence and the availability of
tools to assay tens of thousands of SNPs have made possible genome wide studies in
populations. The studies discussed in this dissertation describe the investigation of two
different types of phenotypic variation in horses that can be investigated using these
tools.
Champagne Dilution
The base coat colors of horses are red and black, encoded by the MC1R locus
(Marklund et al., 1996). The Champagne dilution gene (CH) has been found in several
breeds in the United States, notably the Tennessee Walking Horse, and its effect is to
dilute both the eumelanin (black) and the pheomelanin (red) pigments. The gene is
sometimes confused with the effects of the Cream dilution gene (Cr), which only dilutes
eumelanin. Breeders interested in breeding for this trait need an effective test to
distinguish the different loci. Since the trait is considered attractive, breeders select for
these animals and several families were available for study. This project is the subject of
Chapter 2.
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Genetics Form and Functional Structure: Extreme Lordosis
Some breeders of American Saddlebred horses are concerned about the
occurrence of a condition called swayback that was thought to be hereditary. While some
breeders select against the condition, others do not consider it a serious defect and
tolerate such horses in their breeding programs. However, no one advertises the
condition or actively selects for it. This made it difficult to obtain large and complete
families segregating for this trait. Therefore, to investigate the heredity of this condition,
a genome wide association study was conducted as described in Chapter 3.

Copyright © Deborah G. Cook 2014
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CHAPTER TWO: Champagne Dilution in Horses
Summary
Champagne coat color in horses is controlled by a single, autosomal-dominant
gene (CH). The phenotype produced by this gene is valued by many horse breeders, but
can be difficult to distinguish from the effect produced by the Cream coat color dilution
gene (CR). Three sires and their families segregating for CH were tested by genome
scanning with microsatellite markers. The CH gene was mapped within a 6 cM region on
horse chromosome 14 (LOD = 11.74 for θ = 0.00). Four candidate genes were identified
within the region, namely SPARC [Secreted protein, acidic, cysteine-rich (osteonectin)],
SLC36A1 (Solute Carrier 36 family A1), SLC36A2 (Solute Carrier 36 family A2), and
SLC36A3 (Solute Carrier 36 family A3). SLC36A3 was not expressed in skin tissue and
therefore not considered further. The other three genes were sequenced in homozygotes
for CH and homozygotes for the absence of the dilution allele (ch). SLC36A1 had a
nucleotide substitution in exon 2 for horses with the champagne phenotype, which
resulted in a transition from a threonine amino acid to an arginine amino acid (T63R).
The association of the single nucleotide polymorphism (SNP) with the champagne
dilution phenotype was complete, as determined by the presence of the nucleotide variant
among all 85 horses with the champagne dilution phenotype and its absence among all 97
horses without the champagne phenotype. This is the first description of a phenotype
associated with the SLC36A1 gene.

[Most of the work described in this chapter was published 2008 PloS Genetics 4(9):
e1000195. doi:10.1371/journal.pgen.1000195]
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Introduction
Many horse breeders value animals with specific genetic variation in coat color
variations. Several genes are known which diminish the intensity of the coloration and
are phenotypically described as “dilutions”. Two of these are a result of the Cremello and
Silver loci. The molecular basis for Cremello is the result of a single base change in
exon 2 of MATP gene (Membrane Associated Transporter Protein), also referred to as
SLC45A2 (Solute Carrier family 45 member A2), on ECA21 (Mariat et al., 2002 and
Locke et al., 2001). This change results in the replacement of a polar acidic aspartate
with a polar neutral asparagine in a putative transmembrane region of the protein coded
for by this gene (Locke et al., 2001 and Brunberg et al., 2006). The Cremello gene has
an incomplete dominant mode of expression. In its heterozygous form it dilutes only
pheomelanin (red pigment) whereas homozygosity for CR results in extreme dilution of
both pheomelanin and eumelanin (black pigment) (Adalsteinsson, 1974).
The Silver dilution is the result of a missense mutation of PMEL17
(Premelanosomal Protein) on ECA6. The base change causes replacement of a cytosolic
polar neutral arginine with non-polar neutral cysteine in PMEL17 (Brunberg et al., 2006).
In contrast to CR, the Silver locus is fully dominant and affects only eumelanin causing
little to no visible change in the amount of pheomelanin. The change in eumelanin is
most apparent in the mane and tail where the black base color is diluted to white and gray
(Bowling, 2000).
The coat color produced by the CH locus is similar to that of CR in that both can
cause dilution phenotypes affecting pheomelanin and eumelanin. However, CH differs
from CR in that; 1) It dilutes both pheomelanin and eumelanin in its heterozygous form
and 2) Heterozygotes and homozygotes for CH are phenotypically difficult to distinguish.
The homozygote may differ by having less mottling or a slightly lighter hair color than
the heterozygote. Figure 2.1 displays images of horses with the three base coat colors
chestnut, bay and black and the effect of the CH locus on these colors.
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Figure 2.1: Effect of Champagne Gene action on Base Coat Colors.
A) Chestnut – Horse only produces red pigment. B) Chestnut diluted by Champagne. C)
Bay – Black pigment is held to the points (eg. Mane, tale, and legs) allowing red pigment
produced on the body to show. D) Bay diluted by Champagne
E) Black – Red and black pigment produced, red masked by black
F) Black diluted by Champagne
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Figure 2.2 shows CH foals are born with blue eyes, which change color to amber,
green, or light brown and pink “pumpkin” skin which acquires a darker, mottled
complexion around the eyes, muzzle, and genitalia as the animal matures (Sponenberg
2003). In contrast, foals with one copy of CR also have pink skin at birth but their skin
is slightly darker and becomes black/near black with age. Indeed, the existence of a gene
responsible for a separate dilution was not readily apparent until the discovery that some
horses exhibit a dilution phenotype, without CR. The champagne phenotype is found
among Tennessee Walking Horses, Quarter Horses and several other breeds from the
United States. Here we describe family studies that led to mapping the gene and
subsequent investigations of candidate genes leading to the identification of a genetic
variant that appears to be responsible for the Champagne dilution phenotype.
The purpose of this study was to uncover the molecular basis for the champagne
hair color dilution phenotype in horses. Here, we report a DNA base substitution in the
second exon of the horse gene SLC36A1 (Solute Carrier family 36 member A1) that
changes an amino acid in the transmembrane domain of the protein from threonine to
arginine. The phenotypic effect of this base change is a diminution of hair and skin color
intensity for both red and black pigment in horses and the resulting dilution has become
known as champagne. This is the first genetic variant reported for SLC36A1 and the first
evidence for its effect on eye, skin, and hair pigmentation. So far, no other phenotypic
effects have been attributed to this gene. This discovery of the base substitution provides
a molecular test for horse breeders to test their animals for the Champagne gene (CH).
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Figure 2.2: Champagne Eye and Skin Traits
A, B and C) Eye and skin color of foals
D and E) Eye color and Skin mottling of adult horse
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Materials and Methods
Horses
Three half-sibling families, designated 1, 2 and 3, were used for mapping studies.
Family 1 consisted of a Tennessee Walking Horse (TWH) stallion, known heterozygous
at the Champagne locus (CH/ch), and his 17 offspring out of non-dilute mares (ch/ch).
Family 2 consisted of an American Paint Horse stallion (CH/ch) and his 11 offspring out
of non-dilute (ch/ch) mares. Family 3 consisted of a TWH stallion (CH/ch), 25 offspring
and their 10 non-dilute dams (ch/ch) and 1 dilute (buckskin) dam (ch/ch, CR/cr).
Pedigrees of the three sire families are provided in Figure 2.3.

Figure 2.3: Sire and Offspring Pedigrees
Males are represented with squares and females with circles. Individuals exhibiting the
Champagne Dilution phenotype are represented by solid colored symbols while nonChampagne individuals are represented with uncolored symbols. There were no dams
included for sire families 1 or 2, as sire family 3 was the only family with dams available.
In sire family 3, the sire is number 7 in line I which includes him and the dams. Dam’s
offspring are ones falling between her and the sire or between her and the dam beside her
proximal to the sire. For example: Offspring number II1 in sire family 3 is the product of
dam I1 and sire who is I7. Offspring II2 and II3 in sire family 3 are from dam I2 and sire
who is I7.
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To investigate the distribution of the gene among dilute and non-dilute horses of
different horse breeds, 97 unrelated (within a single generation) non-champagne horses
were chosen from stocks previously collected and archived at the MH Gluck Equine
Research Center. These horses were from the following breeds: TWH (20),
Thoroughbreds (TB, 35), American Paint Horses (APHA, 32), Pintos (5), American
Saddlebreds (ASB, 2), one American Quarter Horse (AQHA), one pony, and one
American Miniature (AMH) Horse.
Hair and blood samples from horses with the champagne dilution phenotype were
submitted by owners along with pedigree information and photographs showing the
champagne color and characteristics of each horse. Samples were collected from the
following breeds (85 total): American Miniature Horse (9), American Cream Draft (1),
American Quarter Horse (27), American Paint Horse (13, in addition to the family),
American Saddlebred (2), Appaloosa (1), ASB/Friesian cross (1), Arabian crossed with
APHA or AQHA horses (3), Missouri Foxtrotter(4), Mule (2), Pony (1), Spanish
Mustang 1), Spotted Saddle Horse (1), Tennessee Walking Horse (19), in addition to the
families).

Color Determination
To be characterized as possessing the champagne phenotype, horses met at least
two of the three following criteria: 1) mottled skin around eyes, muzzle and/or genitalia,
2) amber, green, or light brown eyes, or 3) blue eyes and pink skin at birth (Sponenberg
2003). This was accomplished by viewing photo evidence of these traits or by personal
inspection. Due to potential confusion between phenotypes of cream dilution and
champagne dilution, all DNA samples from horses with the dilute phenotype were tested
for the CR allele and data from those testing positive were not included in the population
data.
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DNA Extraction
DNA from blood samples was extracted using Puregene whole blood extraction
kit (Gentra Systems Inc., Minneapolis, MN) according to its published protocol. Hair
samples submitted by owners were processed using 5-7 hair bulbs according to the
method described by Locke et al. (2002). The hair bulbs were placed in 100 µl lysis
solution of 1X FastStart Taq Polymerase PCR buffer (Roche), 2.5 mM MgCl2 (Roche),
0.5% Tween 20 (JT Baker, Phillipsburg, NJ) and 0.01 mg proteinase K (Sigma-Aldrich,
۫ for 45 minutes, followed by 95◌C
۫ for 45 min to
St Louis, MO) and incubated at 60◌C
deactivate the proteinase K.

Microsatellite Genome Scan
The genome scan was done in polymerase chain reaction (PCR) multiplexes of 3
to 6 microsatellites per reaction. The 102 microsatellite markers used are listed in Table
2-1. Primers for these microsatellites were made available in connection with the USDANRSP8 project (Guérin et al., 1999). Two additional microsatellites were used; TKY329
[18] was selected based on its map location between two microsatellites used for genome
scanning (UM010 and VHL209) and COOK007 was developed in connection with this
study based on DNA sequence information from the horse genome sequence V2 as
viewed in the UCSC genome browser (Kent et al., 2002) in order to investigate linkage
within the identified interval. Primers for COOK007 were designed using Primer 3
software accessed online (Forward, 5’- 6FAM-CATTCCAAACACCAACAACC - 3’),
(Reverse, 5’ – GGACATTCCAGCAATACAGAG – 3’) (Rozen and Skaletsky, 1998).
Microsatellite PCR reactions were done in multiplexes, with anywhere from 3 to
six microsatellites included per reaction. They were grouped according to annealing
temperature and color differences of the dye probes; VIC (green), 6FAM (blue), NED
(yellow). Multiple markers using the same color probe could be used if the product sizes
differed by enough base pairs. PCR product from each assay is filtered to remove excess
fluorescent labeled primers and dried down to be rehydrated with formamide for analysis
in the ABI 310 sequencer. For example: microsatellite LEX020, from table 2.2, has seven
known alleles. The fluorescently labeled product from PCR will fall in the approximate
size range from 198 to 222 base pairs long. Preferentially, the sire will test for two
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differently sized alleles in or near this size range in order for the marker to be
informative. Each offspring will produce results for two alleles as well. If the offspring
has one or both alleles matching only one allele the sire possesses, then that offspring is
deemed informative. The results for that individual are uninformative if it has two alleles
which match both of the sire’s alleles.
Amplification for fragment analysis was done in 10 µl PCR reactions using 1X
PCR buffer with 2.0mM MgCl2, 200 μM of each dNTP, 1 µl genomic DNA from hair
lysate, 0.1U FastStart Taq DNA polymerase (Perkin Elmer) and the individual required
molarity of each primer from the fluorescently labeled microsatellite parentage panel
primer stocks at the MH Gluck Equine Research Center. Samples were run on a PTC-200
thermocycler (MJ research, Inc., Boston, MA) at a previously determined optimum
annealing temperature for each multiplex. Capillary electrophoresis of product was run
on an ABI 310 genetic analyzer (Applied Biosystems). Results were then analyzed using
the current version of STRand microsatellite analysis software
(http://www.vgl.ucdavis.edu/informatics/STRand/).
The initial multiplex scans were conducted on a subset of samples from Family 3
which included sire 3, five non-champagne offspring, and five champagne offspring.
When the microsatellite allele contribution from the sire was not informative, (e.g. the
sire and offspring had the same genotype), dams from family 3 were typed to determine
the precise contribution from the sire. When the inheritance of microsatellite markers in
family 3 appeared to be correlated with the inheritance of the CH allele, then the
complete families 1, 2 and 3 were typed and the data analyzed for linkage by LOD score
analysis (Morton 1956). Final genotypes and LOD scores for marker COOK007 are
given in figure 2.4.
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Figure 2.4: Allele Results and LOD Scores for Microsatellite COOK007
Among the three sire families. Sires A, B and C correspond to sires 1, 2 and 3 in that
order from previous pedigree image. The numbers 324 and 332 are the length of each
allele represented by the microsatellite amplified by the COOK007 primer pair. This
microsatellite is on Equine Chromosome 14 at ~25.6 Mb. The data suggests this
microsatellite is in linkage disequilibrium with the Champagne allele. The first line of
each box identifies the sire family and the microsatellite primer ID. The second line is
the pair of alleles the heterozygous champagne sire possesses for that microsatellite. The
third line represents the champagne offspring and the allele they received from the sire.
The fourth line is non-champagne offspring and the allele they received from the sire.
The fifth line contains the offspring (champagne and non-dilute) whose genotype was
ambiguous and sires contribution could not be determined. The sixth and last line is the
manually calculated LOD score for each family’s data.

47

Table 2.1: Microsatellites Used for Genotype Screening

Marker
Chromosome Alleles
AHT21
01
8
COR100
01
7
HMS15
01
11
VIAS-H34
01
7
ASB8
01
8
LEX020
01
7
ASB41
01
6
NVHEQ100
01
7
ASB18
02
12
A-14
02
10
COR065
02
9
ASB17
02
17
UM007
02
18
COR033
03
9
ASB23
03
7
UCDEQ437
03
8
SGCV23
04
8
ASB22
04
9
COR089
04
10
LEX004
05
6
LEX069
05
7
LEX034
05
6
TKY28
06
7
COR088
06
7
COR070
06
12
NVHEQ82
06
6
VIAS-H7
07
12
COR004
07
6
COR003
08
8
COR056
08
10
LEX023
08
12
ASB14
08
9
HTG8
09
7
ASB4
09
6
COR008
09
12
UM037
09
7
ASB6
10
8
COR048
10
10
ASB9
10
9
NVHEQ18
10
15
COR020
10
7

Size
199-215
212-230
207-245
144-160
138-164
198-222
156-168
197-217
196-213
220-248
280-292
93-125
122-176
222-254
187-213
167-193
221-233
155-177
282-304
282-300
248-262
252-262
280-364
283-297
279-307
133-147
116-146
297-319
195-215
194-220
233-257
118-136
185-197
128-140
251-277
108-124
185-212
178-186
67-113
119-161
162-176
48

Dye
VIC
VIC
6FAM
VIC
VIC
6FAM
NED
6FAM
6FAM
VIC
NED
6FAM
VIC
VIC
VIC
NED
VIC
NED
NED
NED
NED
NED
NED
NED
NED
VIC
6FAM
NED
6FAM
6FAM
VIC
6FAM
6FAM
VIC
NED
6FAM
6FAM
NED
6FAM
VIC
NED

Annealing
Temp
58
56
56
58
58
58
58
58
58
58
58
58
58
58
58
58
56
58
58
58
56
58
58
58
58
58
58
58
58
58
58
58
56
58
58
58
58
58
58
58
58

Optimal
concentration
(uM)
0.09
0.15
0.6
0.7
0.08
0.12
0.3
0.1
0.15
0.8
0.3
0.1
0.05
0.2
0.1
0.1
0.6
0.1
0.1
0.15
0.6
0.05
0.15
0.4
0.2
0.01
0.3
0.5
0.15
0.2
0.15
0.05
0.6
0.7
0.12
0.2
0.6
0.3
0.3
0.06
0.2

Table 2.1: cont…

Marker
SGCV24
SGCV13
LEX068
SGCV8
SGCV10
AHT17
COR058
ASB37
COR069
VHL047
COR002
UM010
VHL209
AHT16
COR014
B-8
COR075
HMS20
L15.2
LEX056
I-18
COR007
LEX055
NVHEQ79
TKY19
COR096
LEX054
COR092
LEX036
LEX073
LEX052
LEX071
HMS42
UM011
COR073
LEX037
SGCV16
HMS47
HTG21
COR016
COR055

Chromosome Alleles
11
10
11
5
11
7
12
8
12
6
12
11
12
12
13
6
13
8
13
4
14
5
14
7
14
6
15
7
15
12
15
8
15
9
16
8
16
9
16
7
16
9
17
9
17
7
17
7
18
9
18
8
18
10
19
6
19
8
19
11
20
7
20
7
20
0
20
11
21
8
21
4
21
5
22
7
22
7
22
7
23
9

Size
125-141
169-179
162-174
126-143
179-187
123-147
218-244
132-146
273-287
134-150
235-243
112-126
91-105
130-153
149-164
88-110
202-220
116-140
147-165
218-234
93-119
163-177
216-232
175-197
147-173
315-329
170-190
191-203
148-170
249-277
208-214
192-211
132-140
167-187
187-205
196-202
154-194
203-215
131-143
184-203
240-270
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Dye
VIC
NED
NED
VIC
NED
6FAM
VIC
VIC
NED
VIC
VIC
6FAM
6FAM
VIC
VIC
6FAM
6FAM
6FAM
VIC
VIC
6FAM
NED
VIC
6FAM
NED
NED
NED
6FAM
NED
NED
VIC
6FAM
VIC
NED
6FAM
6FAM
NED
6FAM
VIC
6FAM
NED

Annealing
Temp
56
58
58
58
56
58
58
58
58
58
58
58
58
58
58
56
58
58
58
58
58
58
58
58
56
58
58
58
58
58
58
58
58
58
58
56
58
58
58
58
58

Optimal
concentration
(uM)
0.5
0.7
0.12
0.2
0.6
0.1
0.1
0.04
0.13
0.05
0.05
0.05
0.2
0.2
0.04
0.1
0.07
0.25
0.07
0.08
0.05
0.04
0.15
0.08
0.04
0.2
0.08
0.1
0.05
0.15
0.05
0.12
0.07
0.1
0.1
0.07
0.12
0.17
0.08
0.12
0.1

Table 2.1: cont…

Marker
LEX074

Chromosome Alleles
24
10

Size Dye
155-175 NED

Optimal
Annealing concentration
Temp
(uM)
58
0.15

COR024
24
6 214-226 VIC
58
0.05
COR061
24
11 197-227 6FAM
58
0.1
COR018
25
7 251-283 NED
58
0.1
NVHEQ70
26
7 192-208 6FAM
58
0.08
COR071
26
8 188-210 6FAM
58
0.05
A-17
26
8 102-118 6FAM
58
0.15
COR017
27
12 241-267 VIC
58
0.15
COR031
27
7 210-224 VIC
58
0.08
COR040
27
8 282-300 NED
58
0.25
UCDEQ425
28
8 236-250 VIC
58
0.1
COR027
29
7 231-255 VIC
56
0.12
COR082
29
7 199-233 VIC
58
0.4
L12.2
29
10 136-156 VIC
58
0.05
LEX025
30
7 152-168 VIC
58
0.04
LEX075
30
8 144-164 6FAM
58
0.04
COR038
31
4 210-214 VIC
58
0.1
AHT33
31
8 151-167 VIC
58
0.15
UM038
X
7 120-144 6FAM
58
0.2
LEX022
X
7 110-124 6FAM
58
0.12
The microsatellites on equine chromosome 14 are highlighted in green. The first column
is the microsatellite name based upon lab location which identified it. The second column
is the chromosome on which the microsatellite is located. The third column shows the
number of alleles possible. The fourth column gives the size spectrum for the alleles,
given in base pairs. The fifth column is the fluorescent dye label for that primer set. The
sixth column is the optimal annealing temperature for PCR of that microsatellite. The last
column is the optimal primer concentration for successful PCR.
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Sequencing
PCR template for sequencing was amplified in 20 µl PCR reactions using 1X
PCR buffer with 2.0 mM MgCl2, 200 μM of each dNTP, 1 µl genomic DNA from hair
lysate, 0.2U FastStart Taq DNA polymerase (Perkin Elmer) and 50 nM of each primer.
Exon 2 of gene SLC36A1 was sequenced with the following primers: Forward (5’-CAG
AGC CTA AGC CCA GTG TC-3’) and Reverse (5’-GGA GGA CTG TGT GGA AAT
۫
GG-3’) at an annealing temperature of 57◌C.
Additional primers used to sequence the
other exons are listed in Table 2.2. Template product was quantified on a 1% agarose
gel, then amplified with BigDye Terminator v1.1 cycle sequencing kit according to
manufacturer’s instructions (Applied Biosystems, Foster City, CA), cleaned using CentriSep columns (Princeton Separations Inc., Adelphia, NJ), and run on and ABI 310 genetic
analyzer (Applied Biosystems). Six samples were initially sequenced: 2 suspected
homozygous champagnes (based on production of all champagne dilution offspring when
bred to at least 10 non-dilute dams), 2 heterozygotes, and 2 non-dilute horses. The results
were analyzed and compared by alignment using Vector NTI Advance 10.3 software
package (Invitrogen Corporation, Carlsbad, California).
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Table 2.2: Primers Used for Exon Screening
Part 1 - Primer sequences for the sequencing of horse SPARC
Exon
#
Forward Primer (5’-3’)
Reverse primer (5’-3’)
1
TCAGGATTGAAAGGGAACTG
ATCTCCACCCAAAAGTCTGC
2
CGAGTTTGGCATCTTCTTGC
AGGTCTGGGAATCAATCAGG
3
CACGCCTTTTCAGCTTGAC
AATTCATGTTCCCCAGAGTCC
4
GCTCTCCTAAATGCTGATTGC
CATCTCCACCTTCTTTTCGTG
5
GGAGCACAAABAGTGGGTTC
GTGGAAGAGATTTGCCCAAG
6
AGCCACTGTGCCAAGGTC
GAGGGGAAGTCTGTGTCCTG
7
CTTTTGTGCATGAGATGCTG
GGAGCAGTGAAGGCTGCTG
8
ATTGCACATCGTCTCCTTCC
GAGTGAGTGCTAATGCTTGAGG
Primer sequences for the sequencing genomic exons of horse SLC36A1
Exon
#
Forward Primer (5’-3’)
Reverse primer (5’-3’)
1
AAGCGCCTGTCTGTCTCTTC
CTCTTCCTCAGCACCAGCTT
2
CAGAGCCTAAGCCCAGTGTC
GGAGGACTGTGTGGAAATGG
3
ATCCCAGGAGCCTCTGTTCT
GAAGCGTTAAGCCAACAGGA
4
CAGCTGCTCAGCATCACAG
CAAAGCAGGAACAGCCCTTA
5
CTCCTGCCATTCCAGTCTTG
AAGGCTCAGTGTGTGAACGA
6
AACCCAGCTCAGACAGTTGG
CCAGAGACCTTTGGCAATGT
7
TTTGTGCATGCTCCAACATT
GTCAAGTCCTCGTGCAAGGT
8
CTTATCGCAGGAGGCAGAAC
GTCCCACATGGGTAACAAGG
9
TATCGTGGAGCTGGTTGTGT
TTCTCTGCACCATCTGGACA
10
CTTGCAGTGAGAGACAGGTTATTC TGGGGAACATACAGCGGT
Primer sequences for the sequencing genomic exons of horse SLC36A2
Exon # Forward Primer (5’-3’)
Reverse primer (5’-3’)
1
CAGAGCCTGCTAAGGCACAC
TTTTCCTCAGCTGCACAATG
2
GACTGTGAGAAGGCCAGGAG
GCTTGTGGAGGCCACTCTAA
3
AAAAGGGCTTGGAAACCAGT
AGCAGAACCTCGCCTTAGGT
4
CTGCCACAGTGTTCTTTCCA
CACCCTGTTGCTGGAGGTAT
5
GGGACAGAAATGGAAACGAC
CCTTGAGGACAGGTCCAAGA
6
CACCCTAACTCGCTGAGACC
ATAAAAGGCTCTGCCCACTG
7
TCCTCTGGCTCTTTGGTTGT
AGGCCAGACGTTGCTTTCT
8
CCTTTCACCCATCAATGGAC
TAGCCTTGAGTCCCCATCAC
9
CTGCTCTGACTCCCTCTTGG
CTGGTTCCTGACCATCCTTC
10
GTCTAAGCCTGGGATGATGC
TCGTAGCTGGTGAATGCTTG
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Reverse Transcription (RT-PCR)
RT-PCR was performed in 25 µl reactions using a Titan One Tube RT-PCR Kit
(Roche) according to enclosed protocol. The primers used are listed in section 3 of Table
S4. RNA from different tissues of non-dilute horses was used to acquire partial cDNAs
containing the first two exons for SLC36A1, first three exons SLC36A2 and first 4 exons
of SLC36A3. The cDNA acquired was sequenced and the resulting sequences were
verified for their respective genes with a BLAT search using the equine assembly v2 in
ENSEMBL (http://www.ensembl.org/Equus_caballus/index.html) genome browser. RTPCR was also performed utilizing RNA extracted from skin, kidney and testes of nondilute animals currently in lab stocks. SLC36A1 cDNA was produced from the skin and
blood using 50 ng RNA per reaction. SLC36A2 cDNA was produced from testes using 1
mRNA per RT-PCR reaction then following up with a nested PCR for shorter product.
SLC36A2 cDNA was produced from skin using 50 ng mRNA per RT-PCR reaction.
Nested PCR was not necessary. SLC36A3 cDNA was produced from testes using 1 ug
mRNA per reaction. 9 µl of initial reaction was visualized on a 2% agarose gel to check
for visible bands of product. When product was not initially detected an additional 20 µl
PCR was performed in reactions as outlined above using 5 µl of RT product in the place
of hair lysate per reaction. Detected product was then sequenced with the protocol listed
above. Sequences were then used in a BLAST search using equine genome assembly 2
on ENSEMBL genome browser to verify the correct cDNA was amplified.

Custom TaqMan Probe Assay
A Custom TaqMan® SNP Genotyping Assay (Applied Biosystems) was designed
for c.188C/G SNP in filebuilder 3.1 software (Applied Biosystems) to test the population
distribution of the SLC36A1 alleles. A similar assay was also designed to test for the
cream SNP. These assays were run on a 7500HT Fast Real Time-PCR System (Applied
Biosystems). All dilute horses tested for SLC36A1 variants were concurrently tested for
SLC45A variants. Horses testing positive for CR alleles were not used in the dataset to
avoid any confusion over the origin of their dilution phenotype.
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Results

Linkage Analyses
Table 2.3 summarizes the evidence for linkage of the CH gene to a region of
ECA14. The linkage phase for each family was apparent based on the number of
informative offspring in each family. Recombination rates (θ) were calculated based on
the recombination rate for all families. Four microsatellites showed significant linkage to
the CH locus; VHL209 (LOD = 6.03 for θ = 0.14), TKY329 (LOD = 3.64 for θ = 0.10),
UM010 (LOD =5.41 for θ = 0.04) and COOK007 (LOD = 11.74 for θ = 0.00) Most
notably, no recombinants were detected among 39 informative offspring between the CH
and COOK007 microsatellite locus.
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Table 2.3: Linkage Analysis between the Champagne Dilution gene and Microsatellite
Markers UM010, COOK007, TKY329 and VHL209.
alleles
Sire contribution
Statistics
LOD
Family (CH) microsatellite
a/b
N1 a+ a- b+ bscore
Θ2
3
(+/-)
UM010
124/108 23 14
0
0 9
5.41
Σ=
5.41
0.04
1
2
3

1
2
3

1
2
3

(+/-)
(+/-)
(+/-)

(+/-)
(+/-)
(+/-)

(+/-)
(+/-)
(+/-)

COOK007
COOK007
COOK007

TKY329
TKY329
TKY329

VHL209
VHL209
VHL209

332/334
332/334
332/324

117/139
111/137
117/139

95/93
91/93
95/93

14
8
17

15
9
18

10
5
7

4
4
10

0
0
0

2
1
0

1
2
1

0
0
0

0
0
1

1
1
1

4
4
9
Σ=

4.21
2.41
5.12
11.74

0

3
3
10
Σ=

1.92
1.34
3.64
6.9

0.1

7
1.49
5
0.46
12
4.08
Σ=
6.03
0.14
The microsatellites are given in the third column. The first column shows the sire
families with data for each microsatellite. The second column gives the sire status which
is heterozygous CH with [+] designating the champagne allele and [–] designating the
non-champagne allele he carries. The fourth column gives the base pair size for the sire’s
alleles for that microsatellite which have been designated allele [a] and allele [b] for the
data in columns 6-9. Column 5 is the number of informative offspring for that sire on that
microsatellite. Column 6 is the number of champagne offspring possessing the [a] allele
and column 7 is the number of non-champagne offspring possessing the [a] allele.
Columns 8 and 9 show the number of champagne offspring and non-champagne
respectively possessing the [b] allele. The tenth column is the manually calculated LOD
score for each sire family for that microsatellite. The sum of LOD scores for all families
for each microsatellite is given below the LODs as Σ=.
1. N = the number of informative meiosis
2. Θ = recombination frequency between that microsatelite and the champagne gene for
all families, combined
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13
12
24

10
4
8

Figure 2.5 identifies the haplotypes for offspring showing recombination between
the genetic markers and the CH locus. Table 2.4 exhibits the microsatellite haplotype
obtained for all individuals tested. The CH locus maps to an interval between UM010
and TKY329 with microsatellites. No recombinants were detected among 39 informative
offspring between the CH and COOK007 locus.

Figure 2.5: Recombinant Haplotypes
Linear relationship from top to bottom between the microsatellites, phenotype, and
genotype of recombinant offspring is shown here, with yellow denoting phenotype when
coloring block of individual and hypothesized association coloring allele blocks. The [a]
alleles represent the speculated paternal champagne genotype and [b] alleles represent the
paternal non-champagne genotype. The marker column gives the approximate genomic
location for each marker on equine chromosome 14.
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Table 2.4: Haplotype Data for 3 Families From Figure 2.3 Pedigree Chart
SIRE 1
Sire 1 Color Sex
UM010
COOK007
TKY329
I-1
CH
Sire
124 124
332 334
117 139
II-1
ch
female
--334 338
117 127
II-2
ch
female 108 124
324 334
139 139
II-3
ch
male
116 124
332 334
117 127
II-4
ch
male
--334 338
127 139
II-5
ch
female 122 124
334 338
137 139
II-6
CH
male
122 124
----II-7
CH
male
110 124
332 342
117 123
II-8
CH
male
--332 332
117 137
II-9
CH
male
122 124
332 338
117 137
II-10
CH
male
122 124
332 338
117 137
II-11
CH
female 116 124
----II-12
CH
female
--332 338
117 135
II-13
CH
male
--332 338
117 137
II-14
CH
female
--332 332
117 137
II-15
CH
male
--324 332
117 135
II-16
CH
male
--332 338
117 127
II-17
CH
female
--332 338
117 127

VHl209
93 95
87 93
93 95
85 95
87 93
85 93
93 95
93 95
95 95
85 95
85 95
93 95
93 95
87 95
87 95
87 95
87 93
87 95

SIRE 2
Sire 2 Color Sex
UM010
COOK007
TKY329
VHl209
I-1
CH
Sire
--332 334
111 137
91 93
II-1
CH
female
--332 338
111 139
87 93
II-2
CH
female
--332 332
111 139
91 101
II-3
CH
female
--332 332
111 139
91 93
II-4
CH
female
----111 139
87 91
II-5
CH
female
--332 334
117 137
87 91
II-6
ch
male
--334 338
111 137
93 95
II-7
CH
male
--330 332
111 139
87 91
II-8
ch
male
--334 338
137 139
93 95
II-9
ch
female
--324 334
137 139
87 93
II-10
ch
male
--332 334
111 127
87 91
The allele designations are the base pair lengths of the amplified microsatellite alleles.
Sire family 3 was the only one with dams included. Each heterozygous champagne sire is
listed first for each family and is in purple. For family of sire 3 the dams are listed below
the sire in pink with their respective offspring immediately below them. Champagne
offspring are in tan and non-champagne are in light blue. The genotypes for each
offspring derived from the sire are colored in tan and blue depending on their inferred
association with the champagne allele from sire.
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Table 2.4: cont…
Family 3
I-7

Color
CH

Sex
Sire

SIRE 3
UM010
COOK007
108 124
324 332

TKY329
117 139

VHl209
93 95

I-1
ch
Dam
108 124
324 338
127 139
85 93
II-1
ch
male
108 108
324 324
139 139
93 93
I-2
ch
Dam
108 124
324 338
127 139
85 85
II-2
ch
male
108 124
324 338
127 139
85 93
II-3
CH
male
124 124
332 338
117 127
85 95
I-3
ch
Dam
122 124
332 338
127 127
85 93
II-4
CH
male
124 124
332 332
117 127
85 95
II-5
CH
male
124 124
332 338
117 127
85 95
II-6
ch
male
108 122
324 332
127 139
93 93
I-4
ch
Dam
108 108
324 324
139 139
85 93
II-7
ch
female 108 108
324 324
139 139
85 93
I-5
ch
Dam
116 124
338 338
127 127
85 93
II-8
ch
female 108 116
324 338
127 139
93 93
I-6
ch
Dam
118 122
324 332
137 139
85 85
II-9
ch
female 108 122
324 332
137 139
85 93
II-10
CH
female 118 124
324 332
117 139
85 95
II-11
CH
male
118 124
324 332
117 139
85 95
II-12
ch
male
108 118
324 324
139 139
85 93
I-8
ch
Dam
--------II-13
ch
female 108 108
324 324
139 139
93 93
I-9
ch
Dam
120 124
334 338
133 137
85 85
II-14
CH
male
108 124
332 338
133 139
85 93
I-10
ch
Dam
108 114
324 342
139 139
93 93
II-15
CH
male
108 124
324 332
117 139
93 95
II-16
ch
female 108 114
324 342
117 139
93 95
I-11
ch
Dam
124 124
332 338
137 139
85 85
II-17
CH
male
124 124
332 332
117 139
85 95
II-18
ch
male
124 124
324 332
137 139
85 93
I-12
ch
Dam
108 116
324 332
133 139
93 95
II-19
CH
female 108 124
324 332
117 139
93 95
I-13
ch
Dam
108 114
324 342
139 139
93 93
II-20
ch
female 108 114
324 342
139 139
93 93
I-14
ch
Dam
122 122
324 332
117 127
85 95
II-21
CH
female 122 124
324 332
117 117
95 95
II-22
CH
male
122 124
332 332
117 127
85 95
II-23
CH
female 122 124
332 332
117 127
85 95
Color legend: Purple = Sire, Pink = Dam, Tan = champagne phenotype (tan data = sire’s
CH associated allele), Red = ambiguous call
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Candidate Genes
Candidate genes were selected on the basis of proximity to the marker COOK007
and genes previously characterized as influential in the production or migration of any
pigment cells. SPARC [Secreted protein, acidic, cysteine-rich (osteonectin)] was located
closest at approximately 90kb downstream from COOK007 and implicated in migration
of retinal pigment epithelial cells in mice (Sheridan et al., 2002). All 9 exons of SPARC
were sequenced. Multiple single nucleotide polymorphisms (SNPs) were found but all
caused synonymous mutations and will not be discussed further in this report.
SLC36A1, A2 and A2 were also proximal to this marker. SLC36A family members
are solute carriers and other solute carrier families have previously been found to play a
role in coat color. SLC36A1 was the second most proximal gene to COOK007 and is
located less than 250kb downstream from COOK007. SLC36A2 and SLC36A3 are coded
for on the plus strand of DNA and are approximately 350 k and 380 k downstream,
respectively from COOK007. A2 and A3 have been found to be expressed in a limited
range of tissues in humans and mice (Bermingham and Pennington, 2004).
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RT-PCR
RT-PCR (reverse transcription-polymerase chain reaction) was used to determine
if SLC36A1, SLC36A2 or SLC36A3 were expressed in skin. SLC36A1 and SLC36A2 were
expressed in skin and their genomic exons were sequenced. SLC36A3 is normally only
found expressed in testes of other organisms and was not detected in equine skin.
Therefore, it was not investigated for the presence of SNPs. Results for RT-PCR of these
three genes are shown in Figure 2.6 and primers used are shown in Table 2.6.

Figure 2.6: RT-PCR Product Results for SLC36A1, A2 and A3.
A) RT-PCR results for SLC36A1, showing mRNA is present in blood and skin of both
dilute horses and lab stock non-dilutes. B) RT-PCR results for SLC36A2 verifying its
expression in skin of lab stock non-dilute horses. C) RT-PCR results for SLC36A3
verifying its expression only in testes with no mRNA detectible in skin of lab stock nondilute horses. (Faint bands observed above 400 bp on gel C were sequenced and did not
show homology to SLC36A3.)
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Table 2.5: Primer Sequences for Reverse Transcription and Sequencing of Partial
cDNAs from mRNA

Gene
SLC36A1

SLC36A2
(outer
long)
SLC36A2
(outer
short)
SLC36A2
(nested)

SLC36A3

Product
(bp)

Exons
Included

169

1-3

AAGCGTCATGCCCG
TGACAAAGAGTGCG

GTGGCAGAAGCGCTGGGC
ACACCTG
348

1-3

GCCCGTGACAAAGA
GTGCG

AAGCGCTGGGCACACCTG

334

1-3

ACCTCAAACTGGAC
CTCAGG

ATGCCTGCGTTCCTCACA

208

2-3

TTGGAAGGGACTAC
AACAGTGAG

GGTTTCGAGGCTGTACAT
CATG

350

1-4

Forward Primer (5’-3’) Reverse primer (5’-3’)
ACCAGCGGTTTGGG ACGGCCACGATGCCCATC
GAAA
A

Sequencing
All 9 exons of SPARC were sequenced. Three SNPs were found in exons but none
showed associations with the champagne phenotype. SLC36A2 was sequenced with
discovery of 9 SNPs in exons. None of the SNPs showed associations with CH. These
SNPs and all other variations detected during the course of this work are described in
Table 2.6.
SLC36A1 was sequenced. Only one SNP was found; a missense mutation
involving a single nucleotide change from a C to a G at base 76 of exon 2 (c.188C>G)
(Figure 5). These SLC36A1 alleles were designated c.188[C/G], where c.188 designates
the base pair location of the SNP from the first base of SLC36A1 cDNA, exon 1 (Figure
2.7). Sequencing traces for the partial coding sequence of SLC36A1 exon 2 with part of
the flanking intronic regions for one non-champagne horse and one champagne horse
were deposited in GenBank with the following accession numbers respectively:
EU432176 and EU432177. This single base change at c.188 was predicted to cause a
transition from a threonine to arginine at amino acid 63 of the protein (T63R).
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Figure 2.7: Genomic Alignment between Homozygous Champagne, Non-dilute, and
Horse Genome Assembly
Allignment is flanked by cut out electropherogram reading of sequencing data for one
homozygous champange horse and one homozygous non-champagne horse. Reading
frame is marked by alternating colors of codons, which code for specific amino acids
which will make up the resulting protein. The bottom of this figure is a diagram of
SLC36A1 highlighting the identified SNP in exon 2 with the sequence and gene layout as
given by Ensembl genome browser equine assembly v2. Blue blocks of gene layout are
exons and red boxes are the 5′ and 3′ UTRs. The purple star denotes the location where
the variant associated with champagne was identified.
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Table 2.6: Sequence Variations Detected
Base
Position
within
Gene
Location location Variation

SPARC

SPARC

SPARC

In 1-2

Ex 2

In 2-3

1353

A>G

ATG

1365

C>T

GAATC
TCCAG

3'flank
GAAT
CTCC
AG
GAGC
TGCT
CTCC

C>T

GGCTG
AGGTG
TC

GAGG
TACG
TGGG

60

157

561

SPARC

SPARC

SPARC

In 3-4

Ex 4

In 4-5

Type

syn

5' flank

G>A

TGCGT
ATTCC
CA

C>T

AAGCC
TCCCC

T
CAGT
CTTC
ACCC
CCTC
CCAA
GGGA
GATT
GGGT
TGGG

87

C>T

1397

G>A

TTCTG
TGAGG
TT
AAGG
ATTGG
TCT

T>C

CAGTC
CCATG
TG

GTGT
GCCA
GGAC

AAAG
GTGCG
AAA

CCTG
TGCTT
TGC

69

1827

C>T

63

mis

residues

Cys>Cys

Cys>Arg

Table 2.6: cont…

Gene

Location

Base
Position
within
location

SPARC

In 5-6

19

G>C

49

C>A

Variation

78

A>G

2181

A>G

SPARC

In 6-7

645

T>C

SPARC

Ex 7

51

A>G

SPARC

In 7-8

95

T>G

SLC36A
1

Ex 2

C>G

G>C

SLC36A
2

5’UTR

76
- 89
from
Start

SLC36A
2

In 2-3

9

C>

Type

syn

mis

del

SLC36A
2

Ex 6

45

C>T

SLC36A
2

In 6-7

1339

T>C

1308

T>A

64

syn

5' flank
CTTTT
CCTTG
GGC
CGAGG
AGAG
ACC
GCTGG
CTGTG
CC
ACCTT
GGGCG
GG
AGTCT
CCCTG
GA
TGGAG
ACCAC
CC
GGTAG
GCTCA
CT
GCAAC
ATTGG
CA
GCTGC
TGAGA
CTGGT
AAGA
AGG
TTACA
A
ATTCA
GGTCT
AC
TAAAG
GAGCT
CA

3'flank
CTTCT
GGGC
TTC
CTGA
ACTG
ACGC
CCCC
C
AGAG
TCAG
GGTC
GCTTT
GTCA
CAG
GTGG
AGCT
GCTG
GATA
TGGT
CAGA
AGGA
CTCCT
GGG
GGGG
TTTGC
ACT
GCTG
CCGC
AGGT
GAGA
CAGT
GATT
GTCA
GAAT
ACTC
ACAT
GCTT
CGAG

residues

Ser>Gly

Thr
>Arg

Tyr>Tyr

Table 2.6: cont…

Gene
SLC36A
2

Location

Base
Position
within
location

Variation

Type

Ex 9

94

C>T

syn

5' flank
CCTCT
ACGTC
TT

syn

ATCGT
CCCCT
TC

155

G>A

3'flank
GGCA
TCCT
GTGC
CTGT
CTCC
CGCG
C

residues

Trp>Trp

Ser>Ser

TCAGC GAAG
CAGAT GATG
In 9-10
23
T>G
GG
GT
GAAG
33
T>G
GATGG ?
CCTCT GGCT
SLC36A
CCCTG CCAT
2
Ex 10
50
T>G
mis GT
GAGC Trp>Gly
GCTCC CAGC
ATGAG GCCC
64
G>C
mis CA
TGGC
Cys>Ser
CCATG CGCC
AGCAC CTGG
67
G>C
mis CA
CCCT
Cys>Ser
TCTGA ACAG
TCCAG ACCA
227
A>G
syn CC
TCTC
Ser>Ser
CCACC TCAG
ATTTT TGAG
265
C>T
mis CA
AATG
Ser>Phe
GATTT TGAG
TCACT AATG
269
G>C
mis CA
GTGC
Cys>Ser
Types of variants found within exons classified as; mis = missense, syn = synonomous.
The base position given within location refers to exons/introns.
SLC36A
2
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Protein Alignment
Figure 2.8 shows the alignment of the protein sequence encoded by exons 1 and 2
of SLC36A1 for seven mammalian species with sequence information from Genbank
(horse, cattle, chimpanzee, human, dog, rat and mouse). The alignment was performed
using AllignX function of Vector NTI Advance 10 (Invitrogen Corp, Carlsbad,
California) and demonstrates that this region is highly conserved among all species. At
position 63, the amino acid sequence is completely conserved among these species, with
the exception of horses possessing the champagne phenotype. This replacement of
threonine with arginine occurs within a putative transmembrane domain of the protein
(Boll et al., 2003).

Figure 2.8: Seven Species Protein Sequence Alignment for SLC36A1 Exons 1 and 2.
The R in red is the amino acid replacement associated with the Champagne phenotype.

Population Data
The distribution of c.188G allele among different horse breeds and among horses
with and without the champagne phenotype was investigated. Table 2.7 is a compilation
of the population data collected via the genotyping assay. All dilute horses (85) not
possessing the CR gene, tested positive for the c.188G allele with genotypes c.188C/G or
c.188G/G. No horses in the non-dilute control group (97) possessed the c.188G allele.
The horses used for the population study were selected for coat color and not by random
selection; therefore measures of Hardy-Weinberg equilibrium are not applicable and were
not calculated.
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Table 2.7: Results for TaqMan Genotyping of c.188 Locus
Champagne (CH/CH or CH/ch)
Horse Breeds
G/G
G/C
American Cream Draft
0
1
American Miniature Horse
0
9
American Quarter Horse
1
26
American Paint Horse
0
13
American Saddlebred
0
2
Appaloosa
0
1
Kentucky Mountain
0
1
Part Arabian
0
3
Pinto
0
0
Pony
0
1
Missouri Foxtrotter
0
4
Mule
0
2
Spanish Mustang
0
1
Spotted Saddle Horse
0
1
Tennessee Walking Horse
3
16
Thoroughbred
0
0
Total

4
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Non-Dilute (ch/ch, cr/cr)
C/C
Total
0
1
1
10
1
28
32
45
2
4
0
1
0
1
0
3
5
5
1
2
0
4
0
2
0
1
0
1
20
39
35
35
97

182

First column contains the horse breeds tested. Second column is for individuals
homozygous for champagne locus. Third column contains champagne heterozygotes .
Fourth column has nondilutes negative for champagne alleles. G is the actual champagne
DNA allele and C is the non-dilute wild type allele.
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Discussion
Family studies showed linkage of the gene responsible for the champagne dilution
phenotype within a 6cM region on ECA14 (Penedo et al., 2005) (Table 1). Based on the
Equine Genome Assembly V2 as viewed in the ENSEMBL genome browser
(http://www.ensembl.org/Equus_caballus/index.html), this region spans approximately
2.86 Mbp (Kent et al., 2002). Within this region, four candidate genes were investigated;
one was selected based on known effects on melanocytes (eg. SPARC), the other three
were chosen for their similarity to other solute carrier genes previously shown to
influence pigmentation (eg, SLC36A1, A2, and A3). While SNPs were found within the
exons of SPARC, none were associated with CH. Of the other 3 candidate genes, only
SLC36A1 and SLC36A2 were found to be expressed in skin cells. Therefore, the exons of
those two genes were sequenced. A missense mutation in the second exon of SLC36A1
showed complete association with the champagne phenotype across several breeds.
While SNPs were found for SLC36A2, none showed associations at the population level
for the champagne dilution phenotype.
This data is the first demonstration for a role of SLC36A1 in pigmentation.
Orthologous genes in other species are known to affect pigmentation. For example, the
gene responsible for the cream dilution phenotypes in horses, SLC45A2 (MATP), belongs
to a similar solute carrier family. In humans, variants in SLC45A2 have been associated
with skin color variation (Graf et al., 2005) and a similar missense mutation
(p.Ala111Thr) in SLC24A5 (a member of potassium-dependent sodium-calcium
exchanger family) is implicated in dilute skin colors caused from decreased melanin
content among people of European ancestry (Lamason et al., 2005). The same gene,
SLC24A5 is responsible for the Golden (gol) dilution as mentioned in the review of
mouse pigment research by Hoekstra (Hoekstra, 2006).
We propose that the missense mutation in exon 2 of SLC36A1 is responsible for
the champagne dilution phenotype. While this study provides evidence that this is the
mutation responsible for the champagne phenotype, the proof is of a statistical nature and
a non-coding causative mutation cannot be ruled out at this point. SLC36A1, previously
referred to by the name PAT1 (proton/amino acid transporter 1) in human and mouse
(Chen et al., 2003), is a proton-coupled small amino acid transporter located and most
68

active in the brush border membranes of intestinal epithelial cells. This protein, also
known as lysosomal amino acid transporter 1, LYAAT1, was first identified in rat brains
(Sagne et al., 2001). SLC36A1 is a symporter that facilitates the coupled transport of H+
and select amino acids from both intracellular and extracellular proteolysis. It functions
in the membrane of lysozomes of brain neurons and the apical membrane of intestinal
epithelial cells. This function is coupled to the V-type H+ ATPase in lysosomes and with
Na+/H+ exchanger in the intestinal epithelial cells, which both provide the gradiant which
drives transport of amino acids to the cytosol (Boll et al., 2003). LYAAT1/SLC36A1 is
localized in the membrane of lysozomes and the cell membrane of post-synaptic
junctions. In lysozomes it allows outward transport of protons and amino acids from the
lysozome to the cytosol (Wreden et al., 2003). During purification and separation of
early-stage melanosomes LAMP1/SLC36A1 is found in high concentrations in the
fraction containing stage II melanosomes (Kushimoto et al., 2001). Perhaps SLC36A1
plays a role in transitions from lysozome-like precursor to melanosome. Since
organellular pH affects tyrosine processing and sorting (Watabe et al., 2004), an amino
acid substitution in this protein may affect cytosolic pH by inhibiting the proper flow of
protons from lysozomes and, therefore, the ability to process tyrosine properly. There
must be an increase in pH, before tyrosinase can be activated. The cytosolic pH gradient
must be maintained for proper sorting and delivery of other proteins required for
melanosome development (Watabe et al., 2008). Thus, the pH gradient of the cell may
be altered by this mutation.
It is hypothesized that disruption of the protein structure by replacement of a nonpolar transmembrane residue with a polar residue results in loss of function for this
protein. This is shown here using a figure depicting the topology of the SLC36A1 gene
originally published by Boll et al (2003). We modified the figure with horse amino acids
overlaying the first two exons with the suspected CH variation shown in red (Figure 2.9).
This image shows the transmembrane location of variation and its vicinity to the
conserved histidine residues which are necessary components of the substrate recognition
site for this transporter. The polar residue would negatively affect the structure of this
transmembrane region and the regions of the protein flanking it, potentially disrupting the
substrate recognition site.
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Figure 2.9: First Two Exons of SLC36A1 of the Horse Overlaid on Mouse Topology
The residue differences between horse and mouse are overlaid in blue and CH variation T
– R is highlighted in red. The beginning and end of the 2 exon segment are denoted by
blue arrows.

Further investigation into this gene/protein product is necessary to elucidate its
role in pigmentation. The transport properties could be compared between wild type and
SLC36A1 and the CH variant using the two-electrode voltage clamp technique in a flux
study similar to the one by Boll et al. to compare the amino acid uptake rates of
SLC36A1and SLC36A2 (Boll et al., 2002). Alternatively, cell cultures containing wild
type and CH variant melanosomes could be compared for processes related to melanin
synthesis and any differences in the ability to transfer melanosomes to keratinocytes. In
another approach, copies of SLC36A1 CH variant could be immunofluorescently labeled
and transfected into other cell lines to identify any change in cellular localization.
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This variant, discovered in association with a coat dilution in the horse, is the first
reported for the SLC36A1 gene. The phenotype resulting from this mutation, a reduction
of pigmentation in the eyes, skin and hair, illustrates previously unknown functions of the
of SLC36A1 protein product. Furthermore, now that a molecular test for champagne
dilution is established, the genotyping assay can be used in concert with available tests
for cream dilution and silver dilution to clarify the genetic basis of a horse’s dilution
phenotype. This will give breeders a new tool to use in developing their breeding
programs whether they desire to breed for these dilutions or to select against them.

Copyright © Deborah G.Cook 2014
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CHAPTER THREE: Genetics of Extreme Lordosis in American Saddlebred
Horses

Summary
Extreme lordosis, also called swayback, lowback or softback, can occur as a
congenital trait or as a degenerative trait associated with aging. In this study, the
hereditary aspect of congenital extreme lordosis was investigated using whole genome
association studies of 20 affected and 20 unaffected American Saddlebred (ASB) Horses
for 48,165 (SNPs). A statistically significant association was identified on ECA20
(corrected P = 0.017) for SNP BIEC2-532523. Of the 20 affected horses, 17 were
homozygous for this SNP when compared to seven homozygotes among the unaffected
horses, suggesting a major gene in this region with a recessive mode of inheritance. The
result was confirmed by testing an additional 13 affected horses and 166 unaffected
horses using 35 SNPs in this region of ECA20 (corrected P = 0.036). Combined results
for 33 affected horses and 287 non-affected horses allowed identification of a region of
homozygosity defined by four SNPs in the region. Based on the haplotype defined by
these SNPs, 80% of the 33 affected horses were homozygous, 21% heterozygous and 9%
did not possess the haplotype. Among the non-affected horses, 15% were homozygous,
47% heterozygous and 38% did not possess the haplotype. The differences between the
two groups were highly significant (P < 0.00001). The region defined by this haplotype
includes 53 known and predicted genes. Exons from three candidate genes, TRERF1,
RUNX2 and CNPY3 were sequenced but distinguishing SNPs were not found. The
mutation responsible for extreme lordosis may lie in other genes or in regulatory regions
outside exons. This information can be used by breeders to reduce the occurrence of
extreme lordosis among their livestock. This condition may serve as a model for
investigation of congenital skeletal deformities in other species.

[Most of the work described in this chapter was published in 2010 Animal
Genetics 41(Suppl. 2), 64–71. doi:10.1111/j.1365-2052.2010.02108.x]
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Spinal Developmental Variations
During vertebral development different spinal variations from the norm can occur.
The three major congenital forms of spinal malformation are extreme
lordosis/hyperlordosis, kyphosis and scoliosis. The most commonly manifested spinal
deformities studied in humans are congenital scoliosis, adolescent idiopathic scoliosis
and Scheuermann's kyphosis. Adolescent idiopathic scoliosis (AIS) is characterized by a
lateral spinal curvature of at least 10 degrees that occurs between age 10 and the point of
skeletal maturity (Ward et al., 2010). Historically, finding the genetic cause for such
deformities has been challenging. In humans, cases of known hereditary spinal
malformations are rare (Winter et al., 1983). In an extended family study of AIS, the
higher risk within the families was attributed to polygenic inheritance (Ward et al., 2010).
Even with the polygenic etiology for AIS, one genetic risk variant near LBX1 on human
chromosome 10 has been identified by whole genome association study (WGAS)
(Takasha et al., 2011).Scheuermann's kyphosis is a result of uneven growth of the
thoracic vertebrae resulting in wedge shaped vertebrae and increased kyphotic curve of
the spine. No particular genetic cause is yet known, but it is believed to be polygenic
(Fotiadis et al., 2008).

Lordosis
Lordosis, specifically the dorsal to ventral concave curvature of the thoracic and
lumbar region of the spine, is normal and healthy in most mammals. However, extreme
lordosis is associated with pathology in horses (Rooney & Pickett 1967; Rooney, 1969).
This condition is also known in horses as swayback, lowback or softback. Rooney &
Robertson (1996) noted that variable degrees of lordosis seem to be common in certain
lines of American Saddlebred horses. Figure 3.1 shows the characteristic conformation
for a horse with lordosis (Figure 3.1 top) and a normal horse (Fig. 3.1middle). A familial
aspect was suspected but not established in previous work. A study of extreme lordosis
among Saddlebred horses led Gallagher et al. (2003) to devise a method to measure the
extent of lordosis and to characterize the variation found among horses in this breed.
Based on this study, a threshold for considering horses to have the condition was defined,
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and 5% of 294 horses were considered affected. Studies of affected families suggested,
but did not prove, a recessive mode of inheritance.
In our experience, breeders are of mixed opinions regarding this trait. Extremely
lordotic horses have not been routinely identified as experiencing pain, and some horses
with this trait have performed well. Most breeders regard the condition as a conformation
defect and avoid breeding stock with this condition. Identifying the genetic
determinant(s) for this condition would provide breeders with the opportunity to better
understand the genetics of the trait and use that information in their selection programs.
Traditionally, family studies have been most useful to identify the genetic
locations for hereditary traits in horses such as the tobiano white spotting pattern, equine
combined immunodeficiency disease and cream coat color dilution (TrommershausenSmith 1978; Bailey et al., 1997; Locke et al., 2001). However, while horses with
extreme lordosis are not uncommon, breeders avoid mating animals they believe likely to
produce affected horses. Consequently, family studies are difficult. However, with the
advent of the horse genome sequence and the availability of dense arrays of singlenucleotide polymorphisms (SNPs) for whole genome association (WGA) studies,
population studies can be used to investigate the genetics of traits in horses (Wade et al.,
2009). The purpose of this study was to determine whether a hereditary component
contributes to the lordotic trait in American Saddlebred (ASB) horses and, if so, to
identify the location of genes responsible for this trait.
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Figure 3.1:Characteristic Conformation Differences Between the Presence and Absence
of Extreme Lordosis.
Horses on top and bottom exhibit extreme lordosis. Horse in the middle is consider
nonlordotic and has a level topline.
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Materials and Methods
Phenotypic Assessment of Lordosis
Phenotypic assessment of lordosis was based on the measurement of back contour
(MBC) (Gallagher et al., 2003). Two points are chosen on the horse’s back, one at the
top of the withers (the highest point of the dorsal spineous process in the region of
thoracic vertebrae T2-T3) and one on the point of the rump (the highest point on top of
the horse’s hips). The shortest distance between those points was measured in
centimeters and designated “A”. Next, the distance along the contour of the back was
measured in centimeters and designated “B”. MBC was calculated as the difference
between “A” and “B”. Figure 3.1c and 3.2 illustrate the points of measurement on a
horse exhibiting extreme lordosis.

Short Back Length

B

A
Long Back
Length

Figure 3.2: Calculating MBC.
Long Back Length – Short Back Length = MBC

Horses Measured for MBC
Measurements and tissue (hair or blood) samples for ASB horses used in this
study came from a sample set of 749 American Saddlebred horses collected from private
and commercial farms in and around Kentucky. The average age was 7.1 years and
ranged from 1 month to 29 years old. All Saddlebred horses used in the Illumina and
Sequenom assays were selected from among this group.
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Horses for Illumina Assay
For the genome scan using the Illumina Equine SNP50 Chip, 40 ASB horses were
selected, based on their lordosis phenotype. Twenty horses were selected based on
having an MBC > 8.0 centimeters and 20 were selected based on having MBC < 5.0 cm.
The control group included 19 half-siblings for horses in the affected group to reduce the
chance of population substructure producing spurious associations.

Horses for Sequenom Assay
A total of 426 horses were selected for a 35 SNPs located in the genomic region
suggested by the WGA study. Three horses were tested in duplicate to control for the
quality of the testing. Twilight, the thoroughbred horse used for the whole equine
genome sequencing, was also tested for quality control of known SNPs located in the
genomic region suggested by the WGA study. Among the ASB horses, 33 (including the
20 original cases) had values for MBC of 7.0 or greater, 287 had MBC <7.0 cm and 106
were parents, siblings or offspring of lordotic horses. The relatives were tested to assist
with haplotype determination.

DNA Extraction
DNA was extracted from blood or hair follicles for testing. DNA from blood
samples was extracted using Puregene whole blood extraction kit (Gentra Systems Inc.,
Minneapolis, MN) according to its published protocol. Hair samples were processed
using 20-30 hair bulbs according to a personally optimized Gentra protocol with a Gentra
DNA purification kit. The hair bulbs were placed in 200 µl Gentra Cell Lysis solution
and 0.01 mg proteinase K (Sigma-Aldrich, St Louis, MO) and incubated at 55°C over
night then DNA was purified by following remaining steps from published Gentra
protocol.
Illumina Equine SNP50 Genotyping
Initial SNP genotyping of 40 samples in the case/control group was performed
utilizing the Illumina Equine 50 SNP chip for a WGA study. DNA was provided to the
core facility at the Mayo Clinic in Rochester, MN for genotyping.
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Sequenom
Ten SNPs from the WGA study and 39 additional SNPs from the EquCab2.0 SNP
database (http://www.broadinstitute.org/ftp/distribution/horse_snp_release/v2/) were
selected for testing using the MassArray iPLEX Gold assay on the Sequenom platform.
Genotyping was performed at Proactive Genomics, LLC; Clemmons, North Carolina.
The 49 SNPS selected were identified as being between positions of the SNPs flanking
the region of interest at base pair 41530793 and 44585118 respectively on ECA 20.
Following testing, 43 of the 49 SNPs provided quality genotyping data. Of these, 35
SNPS, with minor allele frequency > 0.01, were used for final association and haplotype
analysis. Furthermore, 96% of the submitted samples had fewer than 0.05 genotypes
missing and were included in analysis.

Genotyping Analysis
Genotyping data analysis was performed using PLINK v1.06 (Purcell et. al.
2007). Association analysis by case/control chi-square was performed on the Illumina
data. To minimize error, because of the multiplicity of SNPs tested, an MPERM analysis
with 10,000 permutations was done and a statistic, EMP 2 (referred to here as corrected
P) verified possible associations. Once association was identified, different sized
haplotypes were tested by chi-square analysis to identify the size and location of the
highest associated haplotype in the region. Selected haplotypes were phased for all horses
in this study to clarify familial patterns of transmission. Chi-square association analysis
was also performed on the Sequenom data to verify association of the SNPs included
from llumina assay and to identify any new associations. The 35 SNP haplotypes were
then phased to verify familial patterns and to identify possible recombination locations.
Haplotype analysis was also performed in Haploview (Barrett et al., 2005) for validation
of PLINK analysis. Haplotypes were identified using the HAP and PHASE options of
PLINK. Haplotype frequencies were determined by direct counting.
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Sequencing
To investigate candidate genes, exon sequences of two affected horses were
compared to those of two unaffected horses. The two affected horses were selected as
unrelated horses with MBC >7.0 and homozygous for the lordosis-associated ECA20
haplotype. Unaffected horses were selected as unrelated horses with MBC <7.0 and not
possessing the ECA20 haplotype associated with extreme lordosis. When SNPS were
identified and confirmed on these four horses, additional control and case horses were
tested to determine whether there was an association with the lordotic trait. PCR template
for sequencing was amplified in 20 µl PCRs using 1· PCR buffer with 2.0 mM MgCl2,
200 lM of each dNTP, 1 µl genomic DNA from hair lysate, 0.2 U FastStart Taq DNA
polymerase (Perkin Elmer, Waltham, Mass.) and 50 nM of each primer. Template
product was quantified on a 1% agarose gel, then amplified with BigDye Terminator v1.1
cycle sequencing kit according to manufacturer’s instructions (Applied Biosystems),
cleaned using Centri-Sep columns (Princeton Separations Inc.), and run on an ABI 310
genetic analyzer (Applied Biosystems). Primers were designed in Primer 3 (Steve and
Skaletsky 1998) using 8 intronic sequences and seven exonic sequences of TRERF1
(transcriptional regulating factor for CYP11A1), 15 exonic sequences for RUNX2
(transcription factor associate with osteoblast differentiation) and six exonic sequences
for CNPY3 (regulates cell surface expression of Toll Receptor 4) (See Table S1).
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Results

Distribution of MBC
The distribution of MBC values among the 749 horses in this study was similar to
that found by Gallagher et al. (2003). MBC for the 749 ASB horses ranged from 0 cm to
17 cm; shown in figure 3.3. Most MBC values appear to fall within a normal population
distribution with a mean of 3.6 ± 1.9 cm, median of 4 cm and mode of 4 cm. An MBC of
7 cm or greater was selected to classify horses as affected based on this value being
approximately two standard deviations from the mean.

Figure 3.3: Population Distribution of MBC Among ASB Samples
X-axis = MBC measure in centimeters. Y-axis = number of horses.
Whole Genome Scan with Illumina Equine SNP50 Beadchip
The Illumina Equine SNP50 chip (Illumina) was effective in typing DNA from
the initial 40 horses. The 40 individuals had an average call rate of 0.96. After filtering
for minimum minor allele frequency 0.01 and genotyping of 0.90 per SNP; 48,165 SNPs
were retained for data analysis.
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Table 3.1 shows the top 10 statistically significant results from a 2 X 2 chi-square
analysis comparing the distribution of SNPs in the DNA of affected and non-affected
horses. The most significant association was found on ECA20 for SNP BIEC2_532523
(P= 6.69E-06) (Figure3.4). Of the ten most significant P values, 5 occurred for SNPs on
ECA20 in the 531 kb region between positions 42,062,440 and 41,530,973. The
multiplicity of comparisons will result in the spurious discovery of high chi-square
values; therefore, to control for the multiplicity of comparisons, PLINK was used to
conduct a Monte Carlo simulation with 10,000 permutations to calculate a corrected P
value (EMP2) (Figure 3.5). Only the association with SNP BIEC2-532523 on ECA20
remained significant (EMP2 p-value 0.017).

Table 3.1: Results from Illumina Equine SNP50 assay.
CHR BP
SNP-ID
CHISQ

P

20
X
20
7
X
7
28
20
20
20

6.69E-06
7.60E-05
8.12E-05
0.000211
0.000243
0.000261
0.000261
0.000301
0.000301
0.000301

41530793
51065036
42062440
7444796
51061227
18839866
35119684
41576546
41604741
41625809

BIEC2-532523
BIEC2-1124071
BIEC2-532578
BIEC2-978005
BIEC2-1124068
BIEC2-984003
BIEC2-739844
BIEC2-532530
BIEC2-532534
BIEC2-532535

20.28
15.66
15.53
13.73
13.47
13.33
13.33
13.07
13.07
13.07

EMP2
0.01699
0.2554
0.2904
0.6762
0.7091
0.7326
0.7326
0.7931
0.7931
0.7931

Case/Control Analysis: 20 lordotic and 20 normal back Saddlebred horses. Chromosome
location (CHR), base position on chromosome (BP), SNP identifier (SNP-ID), 2X2 chisquare value (CHISQ), P value (P), and P value from Monte Carlo correction for number
of comparison (EMP2) are shown.
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Figure 3.4: The –log P-values from Association Analyses Plotted by Haploview.
Chromosomes are differentiated by color. Illumina genotype results from 20 cases vs 20
controls displayed in haploview. Possible statistical significance indicated on equine
chromosome 20 with –log10 value greater than 5 which is equivalent to P < .

Figure 3.5: Max-T Permutation Results
X-axis = chromosomes, Y-axis = transformed EMP2 value. Ilumina 20 case vs 20
control data. Possible statistical significance is shown on equine chromosome 20.
Among the affected horses with MBC 7cm or greater, 17 out of 20 were
homozygous for the T allele of the [BIEC2-532523 T/C] SNP at base pair location
41530793 on ECa 20. Among the 20 controls, only 7 were homozygous for this allele.
This SNP fell in a larger region of homozygosity spanning approximately 3 Mb from
base position 41,604,741 to 44,512,270, which was identified with the homozygosity
function in PLINK scanning sliding windows of 30 SNPS, moving one SNP at a time
and allowing one heterozygote per window for each segment to be considered
homozygous. A homozygosity plot for chromosome 20 is shown in figure 3.6.
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20
18
16
14
12
10
8
6
4
2
0

AFF
UNAFF

10404275
11031789
11670625
12590353
13069949
13608160
14273135
14915367
15473099
16151524
16710158
17406109
18208610
18845170
19655327
19974998
20441701
21041375
21452428
22490089
23091241
23612299
24284693
25015798
25620981
26395915
27205315
27865962
28610946
29191096
29944101
30556908
31537366
32210308
32787619
33774570
34255597
34674736
35740017
36342831
36882895
37483312
38173223
38940394
39351520
40009923
40720745
41382160
41976634
42586864
43166223
43520722
44434681
44968749
45485938
46246915
46935399
47360615
48063221
48825805
49669036
50016848
50613594
51388683
52182476
52888933
53456980
54037167
54742968
55378449
55958044
56579296
57176850
57618093
58383189
59085596
59732903
60612558
60974072
61605122
62331088
62871489
63227997
64011796
64106040
1619067
2204981
2886598
3613246
4046057
4573482
5197828
5879657
6557120
7148916
7857288
8433849
9075288
981311
BP985960

Figure 3.6: Homozygosity Plot Using the SNP Genotypes of 20 Cases vs 20 Controls on
Equine Chromosome 20.
The Y-axis is the number of horses. The X-axis is base pair location on equine
chromosome 20. The dark blue line is number of affected homozygous for that genetic
region. The pink line represents the number of unaffected homozygous for that region.
This homozygous region spans approximately 3 Mb from base position 41,604,741 to
44,512,270.

Illumina Haploview Analysis
Haploview SNP analysis verified the results gained in PLINK. The most
significant SNPS were still BIEC2-532523 (p-value = 6.6E-6) and BIEC2-532578 (pvalue = 8.1E-5). Figure 3.7 shows the linear relationship of the SNPS on ECA20 for the
region of association. The chi-square values for each SNP are plotted by the red line
above the chromosome. Darker blocks below the chromosome are indicators of high
linkage disequilibrium between the two SNPs connected by that particular block.
Haploview analysis using the four-gamete rule was applied: for each
marker pair, the population frequencies of the four possible two-marker haplotypes are
computed. Recombination is considered to have taken place if all haplotypes were
observed with the minimum frequency of 0.01. Figure 3.8 exhibits the results for the
region of ECA20 showing significant association patterns using four gamete analyses in
Haploview. This region spans from BIEC2-532511 to 532579. The statistical output
from the analysis is given back in table 3.2. Blocks 176 and 179 represent the haplotypes
bearing the most statistically significant association with extreme lordosis.
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Figure 3.7: Haploview diagram. The Two highest CHISQ peaks in red designate the two
most highly associated SNPs; BIEC2-532523 and BIEC2-532578.

Figure 3.8: ECA20 Region of Association from Haploview Four Gamete Analyses.
The SNP IDs are across the top of the diagram. The dark red blocks indicate LD between
alleles. Blue blocks indicate likely recombination hot spots.
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Table 3.2: Haploview Results - Four Gamete Analysis.

Data reflects what is shown in figure 3.9 for the region of ECA20 associated with
lordosis verifying statistical significance seen with other analysis programs.
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Sequenom
To verify the statistical associations found with the Illumina assay, SNPs from the
candidate region on ECA20 were tested, including 10 SNPS from the Illumina Equine
SNP50 chip and 25 additional SNPs from the EquCab2.0 SNP database. Association chisquared analyses were performed separately for the additional 13 affected and 181
unaffected horses not previously tested in the WGA study. The association analysis for
just these new samples is shown in table 3.3 (CHISQ1 and P1). Based on these 13
affected horses, the association with BIEC2-532523 remained statistically significant
with a P-value of 0.036. (Since this was a comparison with new samples, dictated by the
original Illumina assay, no statistical correction is necessary to correct for multiplicity of
testing as done for the previous experiment.) Of the 35 SNPs, 7 showed statistically
significant associations (P< 0.05). When all 33 affected horses and 287 controls were
compared, 21 of the 35 selected SNPs showed statistical significance in their distributions
between the two groups based on their relative frequencies.
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Table 3.3: Results from Sequenom assay Using 35 SNPs from the Candidate Region.
SNP-ID
BP
CHISQ
P
CHISQ2
P2
BIEC2_532523*

41530793

4.416

0.0356

23.72

1.12E-06

BIEC2_532534*

41604741

11.19

0.00082

43.72

3.79E-11

BIEC2_559789

41772507

0.7726

0.3794

5.543

0.01855

BIEC2_559792

41823842

0.2935

0.588

9.102

0.002553

BIEC2_532578*

42062440

5.605

0.01791

42.03

8.99E-11

BIEC2_559853

42305090

0.8888

0.3458

1.363

0.2431

BIEC2_559859

42395887

1.484

0.2231

1.669

0.1964

BIEC2_559873

42482150

2.066

0.1506

7.259

0.007055

BIEC2_532658*

42603867

8.571

0.003415

29.79

4.80E-08

BIEC2_559931

42679616

0.5499

0.4584

4.836

0.02787

BIEC2_559976

42757527

0.4859

0.4858

2.909

0.08809

BIEC2_560005

42806550

1.517

0.2181

3.629

0.05679

BIEC2_560049

42906719

3.046

0.08091

0.002347

0.9614

BIEC2_532826

42983718

1.666

0.1969

13.07

0.0003

BIEC2_560102

43022942

0.8888

0.3458

1.828

0.1763

BIEC2_560144

43069858

0.8056

0.3694

1.711

0.1908

BIEC2_560178

43195488

2.306

0.1288

10.9

0.000963

BIEC2_560197

43241900

1.747

0.1862

3.929

0.04746

BIEC2_560209

43319368

9.93

0.001626

20.93

4.76E-06

BIEC2_560255

43433802

1.213

0.2707

9.956

0.001603

BIEC2_533020

43520722

6.459

0.01104

24.51

7.38E-07

BIEC2_560328

43548897

1.173

0.2788

10.58

0.001144

BIEC2_560360

43605858

1.11

0.2921

9.664

0.001879

BIEC2_560386

43690935

2.254

0.1333

13.48

0.000241

BIEC2_560457

43914236

1.056

0.304

2.418

0.1199

BIEC2_560475

43971596

0.9724

0.3241

2.181

0.1397

BIEC2_560489

44034799

2.722

0.09899

11.67

0.000634

BIEC2_533265

44090171

7.979

0.004733

26.6

2.50E-07

BIEC2_560585

44148267

1.407

0.2356

0.964

0.3262
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Table 3.3: cont…
SNP-ID

BP

CHISQ

P

CHISQ2

P2

BIEC2_560618

44188313

0.09612

0.7565

1.771

0.1832

BIEC2_533376

44241203

3.691

0.05472

19.71

9.03E-06

BIEC2_560705

44337671

1.659

0.1977

1.456

0.2275

BIEC2_560742

44403289

1.312

0.2521

0.8528

0.3558

BIEC2_560796

44484324

1.056

0.3042

8.726

0.0031

BIEC2_533588

44585118

0.5591

0.4546

1.017

0.3132

SNP identifier (SNP-ID), base position on the chromosome (BP) 2X2 chi-square value
comparing the 13 new lordotic horses to 194 controls (CHISQ1), associated P value
(P1), chi-square value for 33 lordotic horses and 296 controls (CHISQ2) and associated P
values (P2) are shown. SNPs that showed statistically significant association with P1 or
P2 are in bold type. SNPs used for the definition of haplotypes for this region are
denoted with “*”.
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Haplotype Analysis
Haplotypes from this region (from bp location 41,530,793 to 44,585,118) were
compared among affected and unaffected horses. A minimum haplotype that included
the maximum number of affected horses and the lowest number of non-affected horses
was identified using the four SNPs BIEC2-532523, 532534, 532578 and 532658 and
spanned 1,073,074 bp. Intervening SNPs did not affect haplotype assignment. These
four SNPs allowed identification of 13 haplotypes. The haplotypes and their frequencies
among affected and unaffected horses are shown in table 3.4. Haplotypes were identified
using the –hap-phase option of PLINK. Haplotype frequencies were determined by
direct counting. Only 4 of the haplotypes had frequencies above 0.05 and had a
cumulative frequency of 0.95 among unaffected horses and 0.93 among affected horses.
The most common haplotype, TGTG, was the one associated with lordosis. Haploytpe
TGTG had a frequency of 0.80 among affected Saddlebred horses and a frequency 0f
0.39 among non-affected horses. The population distribution for the TGTG haplogype
segregated by MBC value can be seen in figure 3.10. Zygosity for this haplotype is
shown for affected and non-affected horses in table 3.5. Among the affected horses, 23
(70%) were homozygous for haplotype TGTG while on 15% of the non-affected horses
were homozygous. Among the 33 lordotic horses, seven (21%) were heterozygous for
haplotype TGTG and three (9%) did not possess haplotype TGTG. Among non-affected,
48% were heterozygous and 35% did not possess haplotype TGTG. Statistical
comparison of the combined data set to the subset of horses with lordosis was highly
significant (P <0.00001).
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Table 3.4: Haplotypes defined by BIEC-532523, 532534, 532578 and 532658 with
frequencies
Haplotype
Affected (N=33)
Non-Affected(N=287)
TGTG

0.80

0.388

CACT

0.03

0.232

CACG

0.06

0.167

TACT

0.04

0.164

TGCG

0.05

0.019

TGTT

0.00

0.012

CATG

0.02

0.003

TGCT

0.00

0.003

CGCT

0.00

0.003

CATT

0.00

0.002

TACG

0.00

0.002

TATG

0.00

0.002

CGTG

0.00

0.002

Haplotype frequencies listed among lordotic and non-affected American Saddlebred
horses.
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Table 3.5: Haplotype by Affected and Unaffected Status
Number of

TGTG

TGTG

No

Classification

Horses

Homozygotes

Heterozygotes

TGTG

Lordotic

33

23 (70%)

7 (21%)

3 (9%)

Non-affected

287

44 (15%)

135 (47%)

108 (38%)

Combined

320

67 (21%)

142 (44%)

111 (35%)

Distribution of haplotypes between affected and unaffected individuals

Figure 3.9: TGTG Haplotype Population Distribution Sorted by MBC.
Results are from all animals genotyped. The Y–axis represents the percentage of horses
with each pair of haplotypes. The X – axis represents the MBC values.
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Haplotype and MBC Related to Age
Extreme hereditary lordosis was the subject of this study, with a focus on earlyonset lordosis which is manifested before the horse reaches maturity. To visualize the
age of affected horses in the study group as related to haplotype and MBC, figure 3.10
exhibits the individuals grouped by haplotype plotted in a graph with MBC values on the
y-axis and age on the x-axis. Interestingly, all of the affected horses under 10 years of
age with MBC greater than 7.5cm were homozygous for the associated haplotype.

TGTG Haplotype compared MBC vs AGE
Heterozygote TGTG
Log. (TGTG haplotype not present)
Log. (Heterozygote TGTG)

MBC (cm)

TGTG haplotype not present
Homozygote TGTG
Log. (Homozygote TGTG)
18
17
16
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14
13
12
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Figure 3.10: Population Distribution MBC vs. AGE.
X-axis = age in years. Y-axis = MBC in centimeters. Interestingly, most of the more
extreme MBC values were found in horses less than 10 years of age.
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Sequenom Haploview Analysis
Solid Spine Analysis: Haploview analysis of Sequenom data verified
associations calculated by PLINK. This method of analysis, searches for a “spine” of
strong LD from one marker to the next along each leg of the triangles in the LD chart.
Figure 3.11 gives the graphic image of results using the solid spine analysis option.
Table 3.6 shows the actual haplotypes, ratios and p-values for each block. Blocks one
and two containing a total of 5 SNPs were most significant with p-values < 9E-11.

Figure 3.11: Haploview Solid Spine Analysis.
SNP region with LD shown by solid red blocks and recombination spots by blue.
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Table 3.6: Solid Spine Analysis Results from Figure 3.11.

Haplotype blocks with frequencies, ratios and p-values.
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Four gamete analysis: Alternate 4-gamete analysis of Sequenom data set gave
results similar to solid spine analyses. Figure 3.12 shows the haplotype image. Table 3.7
gives frequencies, ratios and p-values. Blocks one and three were most significant.
Block one containing 2 SNPS had a p-value of 2.05E-11; whereas block 3 with 6 SNPs
had a p-value of 3.38E-11.

Figure 3.12: Four Gamete Haploview Analysis.
Red blocks indicate LD.
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Table 3.7: Statistics from Four Gamete Analysis in Haploview.

Candidate Genes
The SNPs defined an overall region of homozygosity for lordotic horses from
41.5 Mb to 44.5Mb on ECA20. The annotated horse genome at ENSEMBL genome
browser (Hubbard et al., 2009) showed that this region contains 53 known and predicted
genes. Three genes were selected as possible candidates based on predicted or known
function in other species; sequence comparisons for TRERF1 (15 exons), RUNX2 (seven
exons, eight introns) and CNPY3 (six exons) between normal and affected horses did not
identify SNPs associated with lordosis. Data on SNPs found and their occurrence among
the case and control horses are shown in Table S2.
Figure 3.13 shows the region of association on ECA20 as accessed on ENSEMBL
genome browser with the location of the statistically significant SNPs labeled. The genes
highlighted in blue (CNPY3, TRERF1 and RUNX2) were selected for exon screening
based on location to associated SNPs and possible roles they play in organismal
development. Variations found thus far are in linkage disequilibrium with flanking SNP
from the Sequenom assay.
Only one gene, RUNX2, in this region had been implicated in skeletal defects
based on information from OMIM. From assessment of other likely gene functions,
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candidate gene TRERF1 was identified based on its function as a transcription factor.
Another candidate, RUNX2 has been found to be a scaffold for factors involved in
skeletal gene expression (Stein et al., 2004) and it plays a role in osteoblast and
chondrocyte differentiation and migration (Fujita et al., (2004). The gene CNPY3 was
selected for exon screening because it contains a trinucleotide repeat in exon 2 and
trinucleotide repeat expansions have been identified as playing a role in disease
phenotypes in other species. TRERF1 has 16 exons that were sequenced and compared
for 2 normal and 2 lordotic horses. Likewise, RUNX2 has 9 exons and CNPY3 has 6
exons that were sequenced and compared. No SNPs were found associated with lordosis
in any of the 3 genes screened, compiled results in Table 3.8. Primers used for
sequencing of these genes are compiled in table 3.9.

BIEC2_532523, 41530793, 3.54E-06

BIEC2_532534,
41604741, 7.47E-11

BIEC2_532658, 42603867, 1.29E-07

BIEC2_533020, 43520722, 7.38E-07

BIEC2_560209, 43319368, 4.76E-06

BIEC2_533265, 44090171, 2.50E-07

BIEC2_532578, 42062440, 5.92E-10
BIEC2_533376, 44241203, 9.03E-06

Figure 3.13: Region of Association on ECA 20 as Shown on ENSEMBL Genome
Browser.
Genes highlighted in blue had exons sequenced to screen for additional associated
variations. Green boxes and arrows identify approximate locations of associated SNPS
from table 3.1.
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Table 3.8: Results From Sequencing Candidate Genes; Allele Frequencies
Gene
RUNX2
RUNX2
TRERF1

Location
Intron 1
Intron 5
Exon3

Mutation(q) on EquCab2.0
g.44042908_44042909delAT
g.44188955delT
g.41474935_41474936insCAG

Conclusion
No assoc.
No assoc.
No assoc.
No
CNPY2
None found
evidence
Allele frequencies for variations found in candidate genes RUNX2, TRERF1 and CNPY2
in lordotic and normal horses to investigate association of this gene with lordosis. “p”
represents the number of horses found with the reference type. “q” represents the number
of horses found with the mutation.
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pp:pq:qq
11:02:00
11:6:0
30:16:05

pp:pq:qq
11:04:00
25:5:0
5:01:00

Table 3.9: Sequencing Primers for Candidate Genes
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Gene

ID

Forward Primer

Reverse Primer

BP begin

BP end

RUNX2

e1

5’-cacttcgctaacttgtggctg -3’

5’-cgggtgatctcgagaaagag-3’

44102849

44103416

RUNX2

i 1-2

5’-tgttactcaaaggaaagacaccag-3’

5’-cctttccacgttgataaatatgtg-3’

44042741

44043285

RUNX2

i 1-2

5’-agaggagtccaagtcaattagagc-3’

5’-ttaccagaacacacggaatgtaac-3’

44104971

44105504

RUNX2

e2

5’-attcttggtttttaagctttgctg-3’

5’-aaacactcaaattcatctggacac-3’

44111870

44112245

RUNX2

i 2-3

5’-tgacacccttagttgtctaacgag-3’

5’-attagaagtcaccaatgcttctcc-3’

44114984

44115524

RUNX2

e3

5’-tctcatttagaataaggggtcctg-3’

5’-ggctaccttatctgggatacattc-3’

44117689

44118023

RUNX2

i 3-4

5’-ttgaatgaatgaaacgtaagcaag-3’

5’-gcttctttgtacagagctttcctc-3’

44142759

44143292

RUNX2

e4

5’-agatgatgcttatgaagcagtttg-3’

5’-gtgcaagtgaaacctatgagtctg-3’

44169835

44170215

RUNX2

i 4-5

5’-agatcaagtgtggaaagttcattg-3’

5’-tcttccctatcaagaagaatggtc-3’

44178502

44179044

RUNX2

e5

5’-tctagaaagctttgtgctatgcag-3’

5’-atgagagtgggtttccagttaaag-3’

44188873

44189238

RUNX2

i 5-6

5’-aagtagacccacagagacacacac-3’

5’-tttgcctaaaggaggtagtcattc-3’

44190086

44190643

RUNX2

i 5-6

5’-tgtgctactccctctttacctgag-3’

5’-gggctttacatacattaaccatcc-3’

44201754

44202304

RUNX2

e6

5’-gtttgtcatcttgaaagtgtttgc-3’

5’-aaaatgggacagtaccaatcagac-3’

44218256

44218605

RUNX2

i 6-7

5’-aaagcaaagatacgagatccaaag-3’

5’-gaaattctcctgagggtcataaac-3’

44218899

44219446

RUNX2

e7

5’-tgggaagctaaagttttcttcttt-3’

5’-atatattgatacacttgggacgtg-3’

44220029

44220663

CNPY3

e1

5’-gttgccataggtcgctgaggacaccatcc-3’

5’-gctaactcctaaccaccctctgggcttc-3’

42019587

42020424

CNPY3

e2

5’-gaaatgacgtgagtaggatgagg-3’

5’-tgaagctctaaggaacaaagcag-3’

42023229

42023634

CNPY3

e3

5’-aaaaattccttcccatagagctg-3’

5’-atcttccaatgacacccatatca-3’

42024053

42024453

CNPY3

e4

5’-aaggtgaggtcaagtgtgaagag-3’

5’-tgattctcctgaggaaactgaag-3’

42025686

42026087

CNPY3

e5

5’-cagtttcctcaggagaatcacag-3’

5’-ttgtcgcaggttattctgtacctg-3’

42026068

42026498

Table 3.9: cont.
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Gene

ID

Forward Primer

Reverse Primer

BP begin

BP end

CNPY3

e6

5’-ttaagggtctctcacttcctcac-3’

5’-aggagagaaacgctcagcag-3’

42026614

42027070

TRERF1

e1

5’-acgtgatctgttctcatgttgaag-3’

5’-ttctccagaggtgtctaattctctc-3’

41554583

41554104

TRERF1

e2

5’-cagtgacatgagagtgggtgag-3’

5’-gtgcactttctaagtctacctatgc-3’

41501808

41501430

TRERF1

e 3a

5’-aaatactttcctgtcctttgcatc-3’

5’-cacgtagctggacatggtttc-3’

41476107

41475520

TRERF1

e 3b

5’-ttccctcaagatactcgagacg-3’

5’-catttcttgcatcgacatacg-3’

41475646

41474951

TRERF1

e 3c

5’-cagtattacccacagcagcaac-3’

5’-ccctgtagcacactaagacacc-3’

41475013

41474324

TRERF1

e4

5’-gaagtctcaggtgaggaagagc-3’

5’-taggcacgtggtaatcctgtc-3’

41473091

41472641

TRERF1

e5

5’-tctgaagggtattggagtgatg-3’

5’-aatggaagtgggactgtttgac-3’

41472108

41471624

TRERF1

e6

5’-acctttctggaaaagcaaagtg-3’

5’-aagagctgtcctcatctccaag-3’

41470844

41470388

TRERF1

e7

5’-aaagcccaggtatctgaatcg-3’

5’-taagtatttccagcaccagcac-3’

41467098

41466515

TRERF1

e8

5’-agctccttggagactagtggtg-3’

5’-gtggttaagttggtgtgctctg-3’

41466120

41465719

TRERF1

e9&10

5’-tcttaggatcacgctgtgagg-3’

5’-aaacctgggaaaacagtttcag-3’

41464789

41464197

TRERF1

e 11

5’-agaggaggccccactatctc-3’

5’-aagcagcaattaggacagaagc-3’

41463180

41462699

TRERF1

e 12

5’-ttcagggctgctaaccattatac-3’

5’-ccgatgtcagataccatccttc-3’

41454845

41454445

TRERF1

e 13

5’-ggagtgagaactgaatggatcg-3’

5’-ctctccatagcaggaagtcagg-3’

41452870

41452410

TRERF1

e 14

5’-atgcagaaagaaagcagtgcag-3’

5’-acggagtgaaagaaggaaaacc-3’

41446860

41446362

TRERF1

e 15

5’-tgccctgtcgttagactgtttc-3’

5’-agaccccaaggatggtatgag-3’

41444066

41443606

TRERF1

e16a

5’-caaaccagatgtcagaccacac-3’

5’-aatgtagcccagatgaaacacc-3’

41440537

41439849

TRERF1

e16b

5’-gtggtcgttttcttgcagtttag-3’

5’-accttttcaaatgacgtgtgtg-3’

41439995

41439529

ID column, e = exon and i = intron.

Discussion
The distribution of MBC measurements in this study confirmed the results from
the earlier study that described a normal distribution of the MBC phenotype, with 5%
falling two standard deviations above the mean (Gallagher et al., 2003). In that previous
study, the mean MBC was 4.05 cm, while the mean found in this study was smaller, 3.6
cm. Differences in age of horses may account for this discrepancy, because the previous
study showed a positive correlation for age and MBC; the mean age in the first study was
7.8 years, whereas the mean age in this study was 7.1 years.
The WGA study demonstrated the presence of a recessive gene responsible for the
lordotic trait in horses. This was suggested in the initial WGA study with 40 horses and
the Illumina SNP chip (corrected P = 0.017). The association was confirmed in a
subsequent study with a second set of affected horses using SNPs from this targeted area
(P = 0.036). This haplotype spanned 1 073 074 bases and harbored 53 known and
predicted genes.
The TGTG haplotype was the most common and suggests that the haplotype
occurred in the breed prior to the mutation causing extreme lordosis. If a gene present in
this haplotype was indeed mutated to cause lordosis, then only knowing the specific
mutation would allow us to distinguish between these haplotypes. Of course, mutations
which subsequently occurred within the lordosis-causing haplotype might allow us to use
tests for other markers to identify haplotypes completely associated with extreme
lordosis.
The high frequency of this haplotype and this phenotype among ASB horses
might be the consequence of selection by breeders. If a single copy of the gene produced
a desirable phenotypic effect, such as improved gait, selection for that trait may negate
selection against lordosis and result in a net increase in the frequency of the gene in the
breed. Comparisons of gene frequencies for the TGTG haplotype among horses with
different performance phenotypes will be needed to answer this question.
While the high homozygosity of this haplotype among the lordotic horses strongly
suggests the presence of a recessive gene for the trait, not all lordotic horses were
homozygous for the region. We found five different haplotypes among the lordotic
horses, and 30% were not homozygous for the haplotype associated with the recessive
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lordotic condition. The lordotic phenotype may have multiple possible causes, of which
the hereditary recessive condition is only one. While 70% of the lordotic horses were
homozygous for this haplotype, we observed seven (21%) lordotic horses that were
heterozygous and three (9%) that did not have the haplotype at all (Table 4). There may
be multiple causes of extreme lordosis among Saddlebred horses, and the recessive gene
suggested by this study may be only one of them. Other genes, accidents affecting
skeletal integrity or even management practices may lead to extreme lordosis in the
absence of the recessive gene implicated by this study. Nevertheless, considering the high
prevalence of this haplotype among affected horses, this hereditary recessive condition is
probably the most common cause of lordosis among Saddlebred horses.
Increased homozygosity of this region and frequency of the haplotype in the
population raised a new question: Is this haplotype frequency a result of transmission
distortion (TD) and not just breeder selectivity? TD, also known as segregation
distortion, is a preferentially transmitted haplotype that shows a separation from
Mendel’s law of independent segregation for alleles. A haplotype exhibiting TD in mice,
known as the t haplotype, was first recognized in 1927 (Dobrovolskaia-Zavadskaia,
1927). In mice this haplotype results from a chromosomal inversion including the mouse
major histocompability complex (MHC) on mouse chromosome 17 (Shin et al., 1982,
Silver 1982). The transmission ratio for some of these TD alleles can exceed 95% in mice
(Braden, 1971). TD has been investigated in an extended American Standardbred family
of horses involving the gene A10 in the MHC. Significant TD was found only within that
family and it was theorized A10 is not the cause of the TD but is linked to the gene
responsible in that family (Bailey, 1986). In humans, statistically significant evidence for
TD was noted in male parents of European ancestry for chromosome 6p in the region
containing the genes SUPT3H and RUNX2 (Santos et al., 2009). The synteny this region
shares with the region of interest in Saddlebreds may warrant a new look at the haplotype
associated with extreme lordosis to rule out transmission distortion as a potential cause
for its high frequency.
As noted above, the lordosis region contains 53 known or predicted genes. Three
of these genes; RUNX2, TRERF1, and CNPY3 were selected for exonic sequencing in the
hope of identifying a causative variation. From assessment of other likely gene functions,
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the candidate gene TRERF1 was identified based on its function as a transcription factor.
CNPY3, a trinucleotide repeat-containing gene, was also considered, because repeat
expansion has been shown to play a role in various diseases. Spinocerebellar ataxia type
1 is caused by such a repeat expansion within ataxin 1 gene on human 6p (Kameya et al.,
1994). However, exon sequencing of the three candidate genes did not identify SNPs or
other genetic variations associated with the trait.
Though no associated variations were identified during the course of this project,
RUNX2 could still be considered a viable candidate. Only exonic sequence based on
Ensembl was analyzed. RUNX2 has two isoforms that have different N-termini and are
controlled by two different promoters (Komori and Kishimoto, 1998). Further
sequencing is necessary to ensure both isoforms of the gene were completely covered and
of the known promoter regions were adequately represented. RUNX2 is a transcription
factor with many functions. It is a scaffold for factors involved in skeletal gene
expression (Stein et al., 2004) and has a role in osteoblast and chondrocyte differentiation
and migration (Fujita et al., 2004). It is highly expressed in immature osteoblasts, but
expression must be down regulated for osteoblasts to mature properly (Maruyama et al.,
2007).
Another gene from this region which could be a plausible candidate is CUL7, a
gene implicated in skeletal development and distally closer than RUNX2 to the most
highly associated SNPs in this study. Short stature syndrome of the Yakut people is
attributed to a variation in CUL7, a homozygous T insertion at position 4582 in exon 25.
Two physiological manifestations of this variant in the Yakut are hyper lordosis of the
lumbar region and hypoplasia of the 13th rib (Maksimova et al., 2007). Other CUL7
variations are responsible for 3M syndrome. There is genetic heterogeneity in 3M
syndrome after a large-scale mutation search. The distinguishing features of 3M are
growth retardation, long slender tubular bones, and tall vertebral bodies (Huber et al.,
2009).
Rooney & Robertson (1996) distinguished between senile lordosis and congenital
lordosis in horses. Senile lordosis was a consequence of aging. Congenital lordosis
occurred as a consequence of hypoplasia of the articular facets of thoracic vertebrae and
followed birth as a result of weight bearing (Rooney & Pickett, 1967). We believe that
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the condition we have been investigating in ASB horses is the congenital form because
most of the affected horses were under the age of 10. However, this should be confirmed
by sequential measurement of MBC in horses of different ages, concentrating especially
on young horses, to determine the progression of lordosis. This could be accomplished
with a cohort study, following horses from weaning to 2 years, measuring MBC every 30
days. To facilitate future investigations, a better physiological characterization needs to
be developed; with photos, measurements and radiographs of the spinal facets, noting the
vertebrae involved. This would help better understand the degree of hypoplasia involved
with congenital lordosis.
Discovery of the genetic basis for extreme lordosis is a goal that remains elusive.
In connection with this project, exons of several candidate genes were sequenced.
However, the cause of the trait could be the result of changes in gene expression which
would not be uncovered by exon sequencing. As we learn more about the genome of
animals, we realize that even the introns and the DNA between genes can play a role in
gene regulation. The region of interest might be reduced by further studies using
additional genetic markers from this region, including more SNPs, microsatellites or
other genetic polymorphisms. Deep resequencing of the genes within the target area is a
valid next step toward identifying rare variants associated with lordosis. Even when an
associated variant is located, functional studies may be necessary to elucidate the role the
variant plays, especially a variant not within a gene coding region or known
activator/inhibitor/enhancer site. This was the case when two of the SNPs associated with
increased risk for coronary artery disease (CAD) and myocardial infarction (MI) to
9p21.3, a barren, gene free region (Samani et al., 2007; Schunkert et al., 2008, 2011). It
turned out the CAD risk alleles were located in a STAT1 binding site identified during a
study that identified enhancers in this genomic region (Harismendy et al., 2011).
Another approach to understanding this condition may be to investigate
differences in gene expression between affected and unaffected horses. Discovery of a
gene which shows differential expression would help to focus this work. However, the
choice of tissues and the age at which horses are tested may be factors which confound
such an approach. This could be accomplished with as few as two full sibling weanlings,
one exhibiting the lordotic phenotype and one normal. One would sample tissue from the
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developing thoracic spinal facets from the two. This tissue could then be used in gene
expression analysis. Data could be compared among genes known to interact within the
same developmental pathway for bone development.
More insight into the variation responsible for early-onset extreme lordosis in
horses may be beneficial for studies of human juvenile kyphosis and juvenile idiopathic
scoliosis (IS). As with the horse, these two congenital conditions exhibit an early age of
onset. Familial IS only accounts for 10% of all cases in humans, while 90% appear to be
sporadic with unknown or environmental aetiological factors (Cheng et al., 2007).
Through familial linkage analysis, candidate regions for IS susceptibility have been
identified on human chromosomes 6p, 10q and 18q (Wise et al., 2000). More recently,
regions on 6, 9, 16 and 17 were identified through genome-wide screening (Miller et al.,
2005). It is of particular interest to note that the segment on HSA6 implicated in the Wise
paper is syntenic with the region on ECA20 that was found in this study to be associated
with extreme lordosis.

Copyright © Deborah G. Cook 2014
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CHAPTER FOUR: Discussion of the Champagne and Lordosis Genetic
Studies

Introduction
Chapters 2 and 3 describe studies designed to better understand the genetics of two
traits in horses, namely champagne dilution and extreme lordosis. Champagne dilution
was well known to be the consequence of a Mendelian dominant gene. The task described
here was to identify the chromosome region harboring the gene, locate the gene
responsible and identify the likely mutation. In contrast, extreme lordosis of American
Saddlebred horses was thought to have a hereditary basis but this was not well established.
The results of this study confirmed that the trait did have a strong hereditary component,
localized a major gene responsible for the trait to chromosome 20, suggested the gene
acted with a recessive mode of inheritance, but did not lead to identification of the gene
responsible.
These studies were conducted in a conventional fashion, using the best genomic
tools available at the time, and the results were classic. Linkage was found in family
studies for champagne dilution and association was found with the GWAS study for
extreme lordosis. In both cases the underlying hypothesis being tested was that a single
major gene was responsible for the trait being studied. However, had the genetics of these
traits been different we would have obtained different results. The question arises, how
might the results appear under different genetic models and how might they have been
interpreted?
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Impact of Proper Phenotyping

Champagne Dilution
The Champagne dilution gene dilutes both black and red hair pigment. The effect
of the Champagne dilution gene on red pigment is similar to the effects of the Cream
dilution gene on red pigment. Chestnuts with the Champagne gene are termed Gold
champagne but appear very similar to chestnuts with the Cream dilution (CR) gene
(palominos). Had we not known of the difference and pooled data from the two types of
horses, the results of our study would not have been very clear. Linkage mapping is based
on combined results from testing families. Linkage identified between phenotype and a
marker with a calculated LOD score of 3 or greater is considered to be statistically
significant. Linkage of a genetic marker with Champagne may be identified in one family
but not other families. If the gene segregating with the dilution phenotype had actually
been Cream and not Champagne in one of the families, then the data for that family would
be in conflict with the data from other families. For example: What if three families,
segregating for a hair color dilution gene were genotyped and two of the families had the
CH gene while the third did not? In this case, the LOD the score for family-1 could be 3.4,
family-2 could be 2.7 and family-3 could be -2.6. The score for family-1 is statistically
significant since it is greater than 3.0. The score for family-2 is not statistically significant
by itself but can be combined with that of family-1 to give a total LOD score of 6.1. , The
score from family-3 raises questions because it is less than -2.0 and therefore evidence
against linkage. If we add -2.6 to the other two scores, we still have evidence for linkage
to those markers because the score is +3.5. However examination of the data from each
family would alert us that the genetic basis for dilution in Family-3 lies elsewhere. The
ability to detect genetic heterogeneity is one of the strengths of linkage mapping.
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It is possible for a horse to possess one or two copies of both CH and CR
simultaneously, because they reside on different chromosomes. A horse possessing both
dilutions is called an Ivory Cream and would appear as pale gold. Genotyping a family
with a sire possessing both CH and CR would have proven confounding and inconclusive.
Some dilute offspring would segregate with the sire’s CR allele and some would segregate
with the CH. With the phenotype considered the same, statistical significance would not
be easily attained.
Fortuitous selection of a single true Champagne family would have permitted
discovery of linkage and we could have continued the study and identified the gene and
mutation as described in Chapter 2. However, when we began to use the test for the gene
on the general population we would have found many horses exhibiting a dilution
phenotype without having the Champagne gene. Every horse with the Champagne gene
would exhibit dilution so we would know that the results were correct, except there was
another genetic basis for dilution.
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Examples of Similar Phenotypes Caused by Different Genes

Splashed White
Horses with the splashed white phenotype have blue eyes, and smooth, clearly
defined white markings of the legs underbelly and face. They have the appearance of
being dipped feet first in white paint. Three different variants in two different genes have
been found to be responsible for Splashed White (SW) to date: SW1, SW2 and SW3. When
the first variant responsible was identified, it did not account for all individuals exhibiting
the splashed white phenotype. Upon further investigation, two other genetic variants were
found responsible for the remaining cases of splashed white. SW1 is caused by an 11 SNP
insertion in microphthalmia-associated transcription factor (MITF) promoter 1; SW2 is
caused by a SNP resulting in an amino acid change in paired box domain gene family 3
(PAX3); and SW3 is the result of a 5 base pair deletion in exon 5 of MITF causing a frame
shift and premature stop codon resulting in a truncated protein. These three loci do not
account for all the splashed white phenotypes, leaving more to be discovered (Hauswirth et
al 2012). .

Sabino (White Spotting Pattern)
Sabino is a white spotting pattern in horses with white patches on the legs belly and
face and some white hairs mixed in with the base colored hairs in the midsection of the
body. The variant responsible for Sabino in Tennessee Walking Horses and other light
horse breeds was identified as a single intronic base change that resulted in skipping of
exon 17 in the KIT gene. This particular variant was designated Sabino1 (Sb1), because it
did not explain all the Sabino phenotypes, such as the one possessed by Clydesdale horses
(Brooks et al., 2005). Presumably a different genetic variant is responsible for sabino
color patterns in Clydesdale horses.
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Junctional Epidermolysis Bullosa (JEB)
JEB is an autosomal recessive trait that affects the integrity of the skin and mucosa
and causes neonatal blistering and skin fragility. Candidate genes for the condition were
LAMA3, LAMB3 and LAMC2 genes which make up the three glycoprotein subunits of
Laminin5, a basement membrane protein required for normal function of the dermalepidermal junction. A defect in any one of these genes could have resulted in JEB,
affecting Belgian horses, other draft breeds and American Saddlebred Horses (Frame et al
1988; Kohn et al. 1989; Lieto et al., 2002; Milenokovic et al., 2003). The variant
responsible for JEB in Belgian and other draft horse was a single base insertion that
introduced a premature stop codon in the LAMC2 gene which is located on chromosome 5
(Spirito et al., 2002). However, this mutation did not explain JEB for American Saddlebred
horses. Subsequent studies revealed that 6589 bp deletion spanning exons 24-27 of the
LAMA3 gene on chromosome 8 was the cause of JEB in American Saddlebred Horses. A
random sample set from all cases of JEB, irrespective of breed might not provide for an
informative GWAS. This situation highlights the value of conducting genetic studies
along breed lines.
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Impact of Different Mutations at the Same Locus (Genetic Heterogeneity)

Champagne Dilution
Champagne dilution is the result of one variation within a single gene that accounts
for all cases of Champagne across all the breeds tested. Some genetic investigations do not
end so concisely. Some lead to the discovery that a single variant within that gene does
not explain all cases. Different variations in the same gene may be responsible for a single
phenotype between different families, ethnicities, geographic populations and/or breeds.
This has been noted in a 1989 review of human research of Cystic Fibrosis (CF). About
70% of the cases of CF are caused by one particular mutation and the remainder of the
cases caused by almost 230 other variable mutations within the same gene (Kerem et al.,
1989). Early characterization of the gene responsible for Duchenne’s muscular dystrophy
found multiple deletion events to be responsible for about half of the cases, with other
cases caused by other types of genetic variation within the same gene (Koenig et al., 1987).

KIT Heterogeneity
Heterogeneity within a single gene is seen in horses as well. The KIT gene has
been implicated in many white spotting patterns in mammals. Dominant White (DW) in
horses has been found to be the result of several different spontaneous variations which
arise in the KIT gene. A single mutation was found responsible for dominant white horses
found in the Franches-Montagnes breed, while another variation was found to cause DW in
a family of Arabian horses. For Camarillo White horses yet another mutation in KIT was
found to be responsible (Haase et al. 2007). Since then even more variants have been
found to be responsible for other cases of Dominant White (Haase et al. 2009, Haase et al.
2010). These studies were based on testing individual families. If multiple causative
variants were found in that one gene locus for different families or breeds of horse during
the course of sequencing the exons of SLC36A1 for Champagne, then it could have been
concluded the basis of Champagne was heterogeneous.
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Aggrecan Heterogeneity
Similar results came from investigation of the Aggrecan gene when looking for
the cause of dwarfism in miniature horses. A GWAS revealed a point of statistical
significance on chromosome 1 showing a region where Aggrecan (ACAN) resided as
responsible for dwarfism. Based on sequencing ACAN for dwarf horses it was discovered
that there were at least 4 different recessive variants within the ACAN gene responsible
for dwarfism (Eberth, 2013). The mutations destroy or alter the function of the ACAN
gene and any combination of these 4 mutations (in other words, absence of the normal
allele) result in a dwarf offspring or fetal/embryonic abortion.

GWAS as a Tool to Find Champagne
If families had been unavailable we could have used the SNP chip and we may
have obtained similar results. As long as the sample dilute horses were correctly
phenotyped as Champagne, the results would be clear and significant. Several hundred
SNPs from equine chromosome 14 are represented on the SNP chip. Some of those would
have shown statistically significant linkage to Champagne upon analysis. We would have
then proceeded to select candidate genes for sequencing and found the mutation
responsible. However, if we had grouped all the Cream and Champagne horses as dilute,
and looked for association, the study would have been less conclusive. The number of
horses tested would have been small and the genetic associations for CR and CH might not
have been strong enough to achieve statistical significance for either genetic location.
Considering the strong evidence that the dilution exhibited a clear Mendelian mode of
inheritance, this would have been difficult to explain. The explanation would have to be:
1) The SNPs under study were not sufficiently close to the causative gene for detection. If
the gene fell among those which were not mapped and annotated, relegated to chromosome
UN, then this might occur. 2) There was genetic complexity confounding the simple
model we were testing. Testing a larger number of horses might have provided statistical
significance to genotyping analysis results for CH and CR, but without correct phenotyping
the results would be difficult to decipher. Fortunately, for our actual study we could
distinguish between CR and CH and our results were clear, significant and conclusive.
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Impact of Unknown Mode of Inheritance
Extreme Lordosis
Extreme lordosis is often associated with old horses whose backs sag due to
weakness, overloading or overuse. However there is another form of extreme lordosis
found in many breeds in which the condition appears at birth or within the first two years
(Rooney & Pickett 1967; Rooney, 1969). Early onset extreme lordosis, the focus of our
study, occurs about 1% of the time for most breeds, but in the American Saddlebred an
occurrence rate of nearly 4% was noted, giving rise to the hypothesis that extreme lordosis
has a hereditary component in this breed (Gallagher et al., 2003). At the time we
undertook the investigation its mode of inheritance was not known. It could have been
dominant with incomplete penetrance, recessive or polygenic with a complex inheritance
pattern involving multiple genes of relatively small contribution across the genome.
The lordosis project was different from the search for Champagne: the mode of
inheritance was unknown and adequate family samples for a linkage study could not be
obtained. Many breeders considered it a defect and avoid matings which produce the trait,
thus making them less likely to create families for linkage study. The new equine SNP
chip had just become available when this project began and sufficient population samples
were available for a case vs. control genome wide association study (GWAS). The data
collected identified statistically significant association with a genetic location on equine
chromosome 20 and indicated a recessive mode of inheritance (Cook et al., 2010) If this
significant association had not been found, we would have looked into it as having
potentially polygenic inheritance. Dominance would not have been considered unless
there had been statistical association with a single SNP genotype with little or no
homozygosity among the samples. Complex inheritance is responsible for many
measureable traits studied in livestock such as milk production in dairy cattle and growth
rates in beef cattle. A good review of dairy cattle QTL studies that collated the data across
several mapping projects identified two consensus regions on bovine chromosome 6 that
affect milk yield (Raadsma, 2004). In beef cattle, QTLs have been mapped in association
for growth rate and other meat traits (Kim et al., 2003Nkrumah et al., 2007; Sherman et al.,
2008; Gutiérrez et al., 2009; Snelling et al., 2010), QTL investigations of Osteochondrosis

113

dissecans (OCD) in horses have been undertaken with GWAS using mainly
microsatellites. To date, fourteen quantitatitive trait loci have been found to play a role in
OCD, but only a few match locations between the different breeds of horse (Distl, 2013).
If no single genetic location had been found responsible for lordosis, multiple genetic
locations with possible additive effects would have been included and potential heritability
would have been calculated for each gene or region.

Complex Mode of Inheritance: Size Variation in the Horse
The many modern breeds of horse encompass a large amount of size variation,
from the tiniest of miniature horses at less than three feet tall to the largest of draft breeds
that can top out over 6 feet tall at the withers. In a search for genetic components involved
in size variation, a GWAS was completed with 48 horses across 16 breeds. All horses had
33 measurements taken of the head, neck, trunk and limbs. Four loci were identified on
chromosomes 3, 6, 9 and 11 that together explain 83% of the size variance between these
48 horses (Makvandi-Nejad, 2012).

Impact of Family Availability
If families had been available for use with the SNP chip we may have been able to
identify the trait through linkage studies.. Additional family members could have proven
helpful in defining borders of the associated homozygous region by exposing possible
breaks between the associated haplotype and the location where the gene resides. The
American Saddlebreds overall, show a strong incidence close interbreeding, where highly
favored sires are found only 4 and 5 generations back on both the sire and dam side of the
pedigree for many horses. The lack of genetic diversity in the region would possibly only
prove to be confounding in more closely related individuals with the still limited number
of markers used.
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Current Scientific Tools and Advances

Lavender Foal Syndrome
Lavender foal syndrome is a lethal color dilution in Egyptian Arabian horses with
an autosomal recessive mode of inheritance. Lavender’s phenotype had strong parallels
with two other mutations previously seen in mice one in Ras-associated protein (RAB27A)
and the other in myosin Va (MYO5A). The genetic location for Lavender foal was then
identified using the Equine SNP50 Illumina tool to identify a region of homozygosity
flanking the MYO5A gene (Brooks et al 2010). Since no such genetic signature was found
for RAB27A, this was eliminated as a candidate gene.

Leopard Complex
Leopard complex (LP) is characterized as different white spotting patterns in horses
some involve symmetrical patches of white centered over the hips or complete white body
and may or may not have pigmented oval spots in the white patterned area (Sponenberg,
1990). LP was first mapped to ECA1 with microsatellites in close proximity to Transient
Receptor Potential Cation Channel Subfamily M, Member 1 (TRPM1) (Terry 2004).
Significant down regulation of TRPM1 was detected in the skin and retina of LP
homozygotes using qRT-PCR analysis (Bellone et al., 2008). Subsequent fine mapping
and mutation analysis identified one non-coding SNP that was highly associated with LP,
but it did not show complete LD with LP (Bellone et al., 2010). Recently a 1378 bp
retroviral insertion was found in intron1 of TRPM1 that causes a premature polyadenylation sight. This insertion was identified through novel RNA reads from intron 1 of
TRPM1 found in LP/LP horse skin and retina that had no expression of normal TRPM1
(Bellone et al., 2013).
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Lordosis
Following the discovery of association of early onset extreme lordosis with a
region on ECA1, several candidate genes (CNPY3, TRERF1 and RUNX2) were identified
and sequenced. Sequencing was limited to exons with some partial sequencing of introns
and the 5’ and 3’ untranslated regions. In these cases the hypotheses was that the variant
responsible would be a SNP within an exon which changes the translated product of that
gene in some way. But the variant responsible for lordosis could be any one of the genetic
variations discussed in chapter 1 of this work which qualitatively influence expression.
The variant may not even be found within the affected gene, but may fall within a
regulatory site such as a promoter binding site, inhibitor binding site or splice recognition
site. Since many genes have interactions with other genes down and around many
different pathways and processes, several genes and their products could be affected.
Lordosis may be caused by inadequate development of vertebral facets and. The lordosis
gene may influence traits which are being selected for by breeders, such as a higher head
carriage, more elevated gate or other specific aspect not yet noted which increase the
incidence of lordosis in this breed. Perhaps the genes involved are important for skeletal
or cartilage growth and maturation, since the phenotype develops during the young horses
growth and maturation. Growth and maturation are under strict control during
development giving rise to the idea that it could be caused by a variant involving a
regulatory element. The large size of the homozygous region and density of genes
increases the difficulty in locating the variation responsible. Some of the horses exhibiting
extreme lordosis only possessed one copy of the haplotype of interest or did not possess
the haplotype at all. The gene responsible may flank the homozygous region and separated
from the haplotype during a rare recombination event.
Whole genome sequencing could provide additional info concerning the
developmental pathway and genes involved. Since the first complete equine sequence was
assembled seven years ago, newer sequencing technologies have been developed. Whole
genome sequencing is now more affordable and could be used to find the gene responsible
for lordosis.

One approach to discovering the mutation responsible for the trait would be

the following. A small sample selection of four individuals could be sequenced and
compared: one affected homozygote for the implicated haplotype, one unaffected
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homozygote, one affected without the haplotype and one unaffected without the haplotype.
Closely related individuals could be most informative, but unrelated horses would suffice.
The resulting data might lead to identification of the variant responsible for extreme
lordosis and could highlight variant’s responsible for others pleotropic traits that are
selected for by breeders.

Copyright © Deborah G.Cook 2014
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